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Summary
The high affinity Fc receptor for IgG, FcyRI, is expressed constitutively on the surface o f 
macrophages and monocytes and plays a crucial role in the co-ordination o f the humoral and 
cellular arms o f the human immune system. The activation o f the receptor by aggregation at the 
cell surface leads to recruitment o f accessory signalling molecules the activation o f a wide range 
o f responses including antibody-directed cell cytotoxicity. However, the nature o f the response 
is dependent on the differentiation state of the cell. It has been previously reported that in the 
monocyte-like U937 cell line when the cell is differentiated to a more macrophage-like phenotype 
a molecular switch causes an absolute change in the signal cascade that FcyRI initiates. However 
the effects o f this switch on levels o f gene expression in the nucleus have not been investigated. 
The work presented here details the development o f two complementary assay systems to measure 
the levels o f expression o f the cytokines T N F-a and IL-6 in response to the activation o f FcyRI 
in monocytes and macrophages. A competitive RT-PCR assay was developed to measure levels o f 
mRNA in the cell and a reporter gene assay was developed to study in more detail the promoter 
sequences of the two genes. Both assays were shown to work in principle using the T N F-a 
mRNA and gene promoter, and transfection experiments utilising the T N F-a promoter coupled 
to a reporter gene showed a change in expression in response to induced cell differentiation. 
Although the work proceeded no further than this stage, it provided two valuable tools for further 
examination o f the novel mechanism FcyRI employs to control gene expression.
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Chapter 1: Introduction
1.1 The Human Immune System
The human body is a rich source o f organic materials in a relatively poor environment and as 
such it is an ideal environment for microorganisms to grow in. In some cases these colonising 
microorganisms have no detrimental effect on the body’s normal function and in a few cases, such 
as that o f the bacteria found in the digestive tract, their presence is beneficial. However, most 
microorganisms would severely compromise the human body if  there were no mechanisms to fight 
infection. To combat these infectious agents, the body has evolved an array o f very effective defence 
systems, which can identify and neutralise foreign intruders which get past the physical barriers o f 
the skin and mucosal membranes. These defensive adaptations are collectively called the immune 
system.
1.1.1 The Cells of the Immune System
The basis of the human immune system is a highly evolved family of cells, collectively called 
leucocytes, which arise from haemopoietic stem cells and provide the means to identify and destroy 
foreign antigens. The differentiation of the stem cells occurs along two distinct lineages: lymphoid 
and myeloid.
1.1.1.1 Lymphoid Cell Lines
The lymphoid cell line produces cells called lymphocytes. These cells are responsible for the 
specific recognition o f antigens and thus are the cells that initiate a specific immune response 
against invading microorganisms or other pathogens. Lymphocytes derive from bone marrow stem 
cells and then mature in several locations in the body, producing functionally different, terminally
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differentiated cells. Cells that mature in the thymus are called T cells, while cells that mature in the 
bone marrow are called B cells.
T cells identify pathogens and direct a particular response from the immune system to destroy them. 
Their ability to identify foreign molecules comes from their possession o f a cell surface receptor 
called the T-cell receptor. This is a highly specific but also highly heterogeneous molecule and it 
allows the T cell population as a whole to specifically identify a large range o f foreign pathogens. T 
cells can be identified as belonging to two main groups: T-helper or TH cells and T-cytotoxic or Tc 
cells. Th cells assist other leucocytes in performing their functions, while Tc cells function to destroy 
cells that have been infected by intracellular pathogens such as viruses.
B cells are involved in the production o f antigen-binding molecules called antibodies. Like T 
cells the B cell population carries a cell-surface antigen-binding receptor. This B cell receptor is 
a membrane-bound version o f the soluble antibody molecule. Like the T cell receptor it is highly 
heterogeneous and each individual B cell will bind one specific antigen. When this binding occurs 
the B cell is activated and will divide and differentiate into plasma cells which will then secrete large 
quantities o f soluble antibody specific to the detected antigen.
1.1.1.2 M yeloid Cell Lines
The myeloid cell line generates cells called phagocytes. These cells are primarily involved in the 
destruction o f antigenic particles by engulfing them, internalising in vacuoles and degrading them. 
Phagocytes can be subdivided into two groups: mononuclear phagocytes and polymorphonuclear 
granulocytes.
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Mononuclear phagocytes are derived from bone-marrow stem cells and are relatively long-lived, 
persisting in the body for months or years. Upon exiting the bone marrow, newly formed cells join a 
pool o f cells called monocytes, which circulate in the bloodstream. These circulating cells will then 
migrate from the circulation to specific tissues o f the body where they differentiate into cells called 
macrophages. Macrophages throughout the body do not exist as a single population o f uniform 
cells, but rather as a number o f tissue-specific sub-populations. They are concentrated in the tissues, 
such as the liver (where they are called Kupffer cells, the kidneys (mesangial phagocytes) and the 
lungs (alveolar macrophages), where they are most likely to encounter the pathogenic particles that 
they are designed to eliminate. The work presented in this thesis is focused on gene function in 
macrophages and therefore their diversity, activation and function are covered in greater detail in 
Section 1.3.
Polymorphonuclear granulocytes are derived from bone marrow stem cells like mononuclear 
phagocytes but have a much shorter life span, living in the circulation for only 2 to 3 days. Several 
types have been identified on the basis of differential staining with cell dyes, the most common 
of which are neutrophils, basophils and eosinophils. All granulocytes possess a highly convoluted 
nucleus and numerous cytoplasmic granules. These granules are compact stores o f enzymes and 
other molecules used to digest antigenic particles and elicit further immune responses. The granules 
can either be used internally where they fuse with vacuoles containing phagocytosed particles, or 
their contents can be released into the extracellular environment when the granules fuse with the 
plasma membrane; a process called degranulation.
1.1.2 Soluble Molecules of the Immune System
In addition to the diverse family o f cells described above, a large array o f soluble, extracellular
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molecules are involved in the mediation o f the immune response. Typically, these molecules are 
generated in lymphocytes and then secreted into the serum, normally in a controlled manner, in 
response to a specific signal. Two types o f molecules particularly relevant to the work described in 
this thesis are immunoglobulins, or antibodies, and cytokines.
1.1.2.1 Immunoglobulins
Antibodies or Immunoglobulins (Ig) are a family o f glycoproteins that specifically bind to antigen 
molecules and particles. They are soluble and found in the serum as well as most tissue fluids. There 
are five structurally and functionally distinct classes: IgG (gamma), IgA (alpha), IgE (epsilon), IgD 
(delta) and IgM (mu).
The basic immunoglobulin molecule is formed from 2 pairs o f identical polypeptides called the 
heavy and light chains. Each chain consists o f several similar domains called immunoglobulin 
folds. The typical immunoglobulin fold is formed from two layers o f extended (3-sheets, one o f 
three (3-strands the other o f four (3-strands. These two sheets are roughly parallel to each other and 
surround an inner portion packed with hydrophobic amino acid side chains.
The light chain consists o f two Ig domains. The N-terminal domain exhibits great variation in its 
amino acid sequence and is classified as a variable-type domain and specifically referred to as the 
VL or variable-light chain domain. The C-terminal domain sequence is more conserved and is thus 
classified as a constant-type domain and specifically called the CL or constant-light chain domain. 
Humans, and indeed all vertebrates, possess two types o f light chain, called kappa (k ) and lambda 
(A,). An individual immunoglobulin molecule can possess either two K-chains or two A-chains but 
not one o f each type.
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The heavy chain consists o f between four and five Ig domains. The variable/constant system o f 
classification employed for the light chain is also used to identify the domains o f the heavy chain. As 
with the light chain, the N-terminal domain o f the heavy chain is a variable type, specifically the V H 
domain. The remaining domains are all constant-type and simply numbered one to three (or four) 
from N- to C-terminal (CH1, CH2, CH3, CH4). There are five types o f heavy chain in humans, y, a ,  5, 
e, and p, each immunoglobulin containing an identical pair o f one o f these types. The five types o f 
heavy chain define the five classes o f immunoglobulin described above.
The heavy and light chains are joined together by covalent disulphide bridges and form a Y-shaped 
molecule with two antigen-binding arms, the Fab region (from antigen-binding Fragment), and a tail, 
the Fc region (constant Fragment) (see Figure 1.1.1.1). The variable domains at the N-termini o f 
a heavy/light chain pairing align to form a hyper-variable binding pocket specific for one particular 
antigen molecule. The five classes o f immunoglobulin all share this basic structure although two 
of the five are typically found in multimeric forms. IgA typically exists as a dimer, with the two Ig 
molecules facing in opposite directions and linked through a protein assembly called the J-chain. 
IgM monomers form a pentameric ring structure, again held together by a J-chain assembly. The 
structures o f all five classes o f immunoglobulin are shown in detail in Figure 1.1.2.1.
The antigen binding capacity o f immunoglobulins allows them to both neutralise antigen particles 
and identify them for disposal by the immune system. The five classes are found in differing 
concentrations at different locations within the body and serve specific functions.
IgG is the most common immunoglobulin class, making up 70-75% o f the circulating pool 
under normal conditions. It is also found in the interstitial fluids o f the tissues and is the only
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immunoglobulin class that can cross the placenta, via receptor-mediated endocytosis, to provide the 
gestating fetus with an immune capability.
IgM is usually confined to the circulation and, as a pentamer, is most effective at cross-linking 
antigenic particles. It is the first immunoglobulin produced after a primary immune challenge, 
typically being produced 2 to 3 days after an antigen is first detected by the body. After this primary 
phase, it is replaced by IgG as the principal immunoglobulin to respond to subsequent challenges by 
the same antigen (a change known as isotype switching).
IgA is the primary immunoglobulin found in the secretions o f mucosal membranes such as those in 
the gastro-intestinal and respiratory systems. Here it defends against microbial invaders which have 
entered the body through the air or in ingested food. IgA is also the main immunoglobulin present 
in mammalian milk and provides the neonate with much needed immunity against gastro-intestinal 
infections.
IgE is the class o f immunoglobulin associated with the allergic response, also known as type I 
hypersensitivity. This response, against harmless environmental antigens such as pollen or animal 
hair, is characterised by the release o f molecules which generate an acute inflammatory response. 
IgE plays a central role in the sensitization and activation o f the mast cells that are the primary 
source of these inflammatory agents in an allergic reaction. This immunoglobulin class is also 
central in the defence against parasitic infestation.
IgD is the least understood o f the five immunoglobulin classes and its functions are not clear. It 
is also the least abundant in serum, normally occurring at trace levels o f less than 1% o f the total 
amount of immunoglobulin, but it is found in abundance in the membranes o f B-cells, leading to the 
suggestion that it plays a role in antigen-triggered lymphocyte differentiation..
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Antigen-binding Sites
(hypervariab le  regions)
Fab Region
■■■; ■
C l
C h2
Fc Region
Ch3
Figure 1.1.1.1 Basic S tructu re  of Im m unoglobulin Molecule
The basic structure of an immunoglobulin monomer is illustrated. The heavy and light 
chains each consist of a number of Ig-family domains, the heavy chain consisting o f 4 
such chains and the light chain consisiting of two. The variable-type domains at the end 
o f each arm of the structure contain the hypervariable regions which form the specific, 
antigen-binding pockets. The heavy chains are linked by several covalent bonds formed 
by disulphide links.
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A) B) C)
D) E)
Key @ Heavy Chain Ig Domain Ig C la s se s
0 Light Chain Ig Domain
A) IgG
B) IgE
• Polysaccharide Chain
C) IgD
— ' Disulphide Bridge D) IgM (pentamer)
3D J-Chain E) IgA (dimer)
Figure 1.1.2.1 S tructures of the Five Im m unoglobulin Classes
The five classes o f immunoglobulin share the same basic, monomeric structure but feature 
unique characteristics that allow them to carry out their specific functions within the immune
system.
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1.1.2.2 Cytokines
The term cytokine refers to a wide range of hormone-like peptides and glycopeptides that act as 
messengers and elicit cellular functions in every area of the immune system. They are classified 
as belonging to one of a number of a number of cytokine families that contain functionally or 
structurally similar members. They are functionally active at very low concentrations (several pg/ml) 
due to the high affinity with which specific cell-surface receptors bind them.
Interferons are primarily characterised as antiviral agents but they are also function as regulators 
o f cell growth and differentiation. There are three types: IFN-a, IFN-p and IFN-y. IFN -a, o f which 
there are at least 20 variants, is produced by leukocytes in response to activation by viral particles or 
nucleic acids and has a substantial antiviral effect. IFN-p is a single protein produced by fibroblasts, 
again in response to viruses or nucleic acids, and has similar antiviral capability to IFN-a. IFN-y 
is a much less potent antiviral agent than IFNs - a  or -p, and is produced in a single form by 
lymphocytes. It is of particular relevance to the work presented in this thesis as an experimental 
regulator o f the differentiation state o f the U937 cell line (see Section 2).
Interleukins are a large family and were originally defined as molecules that are made by and act 
on leukocytes, although it has subsequently been shown that there are exceptions to both these 
rules. They are mainly produced by T-cells and display a wide variety of functions, with indivdual 
examples often displaying multiple functions dependent on their location in the body and the cells 
they interact with. IL-6, one o f the two cytokines being examined in the work in this thesis is 
described in greater detail below.
IL-6 is produced by many different cell types. The main sources in vivo are monocytes, fibroblasts
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and endothelial cells, although macrophages, T-cells, B-cells, smooth muscle cells and mast cells 
amongst others, will produce IL-6 upon stimulation The IL-6 molecule is a chain o f 185 amino 
acids generated from a precursor protein o f 212 amino acids. It is glycosylated at several residues 
and variation in the size o f  these post-translational modifications leads to several different forms 
being secreted, with molecular masses ranging from 21.5 to 28 kDa. The multi-functionality o f 
IL6 is evident from the long list o f alternative names it possesses (over 30). It plays roles in the 
differentiation o f stem cells into neutrophils and monocytes, the differentiation o f B-cells into 
immunoglobulin-producing plasma cells and the secretion o f Ig from these cells to the extent that 
serum levels o f IgG can rise 120-400 fold. IL-6 also effects non-immune system cells, promoting 
proliferation o f kidney mesangial cells and keratinocytes. It is also one o f the major growth 
regulation factors in many human myelomas. The IL-6 gene is approximately 5kb in length and 
contains five exons. Its promoter sequence contains a number o f regulatory sequences which allow 
induction by a number o f stimuli, including glucocorticoids, cAMP and NF-kB (see Section 1.4).
A third family o f cytokines of particular relevance to the work in this thesis are the tumour 
necrosis factors (TNFs). This family consists o f two molecules ( a  and (3). T N F-a is the second 
cytokine examined in the work presented here. It is secreted by macrophages, monocytes and other 
lymphocytes, and is a primary mediator o f the inflammatory response together with IL-1 and IL-6. 
Human TN F-a is a non-glycosylated 17 kDA polypeptide o f 157 amino acids. The secreted form 
is produced from a 233 amino acid precursor protein by the post-translational modification o f an 
N-terminal signal peptide. It shares approximately 30% sequence identity with TNF-J3 and forms 
dimers and trimers in vivo. The T N F-a mRNA is approximately 3.6kb in length and comprises four 
exons.
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1.2 Fc Receptors
1.2.1 Im m unoglobulin Classes and Fc Receptor Families
The antibody or immunoglobulin (Ig) molecules of the mammalian immune system play a vital role 
in the specific detection and removal o f antigenic particles from the body. While they may appear 
superficially similar in structure, there are five distinct classes, found in different locations within 
the body and which have very different roles in the immune system.
The five classes of immunoglobulin are: IgG, IgA, IgM, IgE and IgD (see Section 1.1.3). The 
functionality o f each class of immunoglobulin molecule is mediated by cell surface receptors and 
a different family of receptors has evolved for each class of immunoglobulin. These receptors all 
bind the immunoglobulin molecule on the Fc portion and are therefore known as Fc receptors with 
their nomenclature being derived from the particular class o f immunoglobulin they bind. This is 
summarised in Table 1.2.1 below:
Table 1.2.1 Im m unoglobulin Classes and Fc Receptors
Immunoglobulin Class Fc Receptor
IgG FcyR
IgA FcaR
IgM FcjiR
IgE FceR
igD Fc6R
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There are several different receptors in each Fc receptor family and these are not necessarily 
structurally related but are nevertheless are given the simple nomenclature FcRI, FcRII, FcRJII 
and so on. As with the immunoglobulins they bind, the Fc receptor families have distinct cellular 
distributions and this defines the nature o f the immune response to antigen recognised by antibodies. 
For example, the high affinity receptor for IgE, FceRI, is found on the surface o f mast cells and its 
activation through the binding o f IgE immune complexes results in the classic features o f the allergic 
response; the activation o f FceRI leads to mast cell degranulation and release o f inflammatory 
factors such as histamines and leukotrienes.
The work presented here focuses on the IgG activation o f macrophages through Fey receptors.
1.2.2 Fey Receptors
1.2.2.1 Fey Receptor Classes
There are 3 classes o f Fey receptor. These have distinct characteristics but are closely related in terms 
of structure, and their genes are located in close proximity to each other on human chromosome 1, 
suggesting a common evolutionary origin. The basic structures o f the Fey receptors are illustrated in 
Figure 1.2.1.1 and their characteristics are summarised in Table 1.2.2 below.
All 3 classes o f Fey receptor are type 1 integral membrane proteins with a single extracellular 
region and (with the exception o f the GPI-anchored FcyRIIIb subclass) single membrane-spanning 
and intracellular regions. The extracellular region in all three classes is composed o f several 
domains belonging to the Ig superfamily. These are globular domains comprised o f seven (3-strands 
arranged in two P-sheets o f three and four strands. This type o f domain is also found repeated in
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Table 1.2.2 Fc G am m a Receptors
Receptor
Class
CD
Number
Molecular
Weight
Affinity Expression
FcyRI CD64 72kDa High
Macrophages, Monocytes, 
Neutrophils+, Eosinophils*
-
FcyRII CD32 40kDa Low*
lUil
■ .
Monocytes, Macrophages, 
Neutrophils, Basophils, 
Eosinophils
FcyRIII CD16 50-80kDa Low-Medium*
Monocytes+, Eosinophils+, 
Macrophages, Natural Killer 
Cells, T Cells
* only binds polymeric IgG
+
expression is inducible
immunoglobulin molecules, from where it derives its name.
1.2.2.2 FcyRI: S tructu re  and Function
FcyRI is the high affinity receptor for IgG and can bind monomeric IgG with an association constant 
(Ka) of 10s- 109 M '1 under physiological conditions. Its extracellular region comprises 292 amino 
acids and consists of 3 Ig superfamily domains. The Ig domain is the repeated tertiary structure in 
immunoglobulin molecules (hence its name) and is also found in a wide range of other proteins. It 
consists o f seven (3-strands o f amino acids arranged in two (3-sheets o f 3 and 4 strands. The outer 
two domains of FcyRI share sequence identity with the two extracellular domains found in FcyRII 
and FcyRIII. The third domain, closest to the cell membrane, differs significantly from these and is 
essential for binding IgG at high affinity. However, experiments involving the generation o f chimeric 
receptors, where domain 3 of FcyRI is added to the two domains of FcyRII, have indicated that the 
addition of domain 3 is not sufficient to confer high affinity binding characteristics to FcyRII. T his
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suggests that small variations in the amino acid compositions o f domains 1 and 2 between FcyRI 
and FcyRII, which allow monoclonal antibodies to distinguish FcyRI from FcyRII, are also vital for 
conferring the high affinity o f ligand binding characteristic to FcyR I.
As with the other high affinity Fc receptors such as FcaRI and FceRI, FcyRI does not possess 
any identified signalling motifs within its intracellular tail. These motifs would normally be used 
to recruit and activate intracellular signalling molecules such as soluble tyrosine kinases and 
monomeric G-proteins as the first steps in a signal cascade. In order to activate signal transduction 
pathways within the cell FcyRI must recruit molecules that possess these sequences.
FcyRI activates a large array o f cellular functions. It is the mediator o f endocytosis and phagocytosis 
o f IgG. Because FcyRI can bind monomeric IgG, these functions are only activated when IgG is 
complexed with antigen and can cross-link multiple receptors. FcyRI also activates intracellular 
signalling pathways. Because it has no intrinsic signal activation m otif within its intracellular tail, 
the receptor does this by recruiting accessory molecules embedded in the cell membrane which do 
possess such sequences in their cytosolic regions. The two molecules particularly relevant to the 
work presented in this thesis are the gamma (y-) chain and FcyRII.
1.2.2.3 The Gamma Chain
The gamma (y-) chain was first identified as a component o f the multi-subunit high affinity receptor 
for IgE, FceRI, on mast cells (Perez-Montfort et al, 1983). The y-chain was found to associate with 
the a-chain which binds IgE and was necessary for the cell surface expression o f FceRI. Later the 
same y-chain was shown to associate with the a-chain o f FcyRI in the membrane o f macrophages 
(Ernst et al, 1993). The y-chain is a 7 kDa, type I membrane-spanning polypeptide and is normally
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found as a homodimer in the membrane; the two chains being linked by a single disulphide bridge 
(see Figure 1.2.1). The y-chain belongs to a family o f membrane-associated signal transduction 
molecules that also includes the ^-chain component o f the T-cell receptor (Orloff et al, 1990), and 
it shares the distinct structural characteristics shown by these molecules. The extracellular portion 
of the chain is minimal, the only notable feature being the presence o f a cysteine residue that 
forms a covalent disulphide bridge, to form the homodimer. The membrane-spanning region is a 
single a-helix and the intracellular domain features a classic ITAM signalling m otif (Samuelson 
et al, 1992). The y-chain associates with FcyRI through non-covalent interactions between their 
transmembrane a-helices (Harrison et al, 1995).
1.2.2.4 FcyRII
FcyRII is structurally related to FcyRI (see Figure 1.2.1) with two important exceptions. It has 
only two extracellular Ig domains and binds IgG at lower affinities than FcyRI. In fact, it is unable 
to bind monomeric IgG at detectable levels and will only bind IgG when aggregated as part o f 
an immune complex. It also has a more extensive cytoplasmic region than FcyRI, and includes 
an intracellular signal-mediating motif. The two subclasses o f FcyRII, a and b, possess motifs 
which elicit functionally opposite responses. FcyRIIa has a non-classical ITAM (Immuno-Tyrosine 
Activation Motif) sequence, while FcyRIIb has an ITIM (Immuno-Tyrosine Inhibition Motif).
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Fc-yRllla FcyRlllbFcyFllla FcyRllb
y-chain
Figure 1.2.1 Fc gam m a Receptors
Schematic representation of the three classes o f Fc gamma receptor as well as the y-chain 
accessory signalling molecule embedded in the cell plasma membrane (Top of picture 
shows the extracellular environment while the bottom shows the cytsol of the cell). Both 
the y-chain and FcyRIIa feature ITAM (Immuno-Tyrosine Activation Motif) sequences in 
their cytosolic tails while FcyRIIb feature an ITIM (Immuno-Tyrosine Inhibition Motif) 
sequence.
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1.2.3 FcyRI-Mediated Cell Signalling in U937 Cells
The U937 cell line provides an experimental system whereby the functionality o f FcyRI can be 
examined in the context o f a controlled differentiated cell type. Treatment with dbcAMP results 
in the U937 cell differentiating from its inactive monoblast-like phenotype to a more macrophage­
like state (Sheth et al, 1988), while treatment with IFN-y results in cell activation and a functional 
monocyte-like phenotype (Ishizuka et al, 1995). This model system allows controlled differentiation 
and thereby overcomes the major problem o f heterogeneity normally encountered when using 
macrophages harvested from tissues.
While FcyRI will bind and internalise monomeric IgG, aggregation through binding immune 
complexes is required for internalisation and activation o f the full range o f cellular responses. These 
responses differ between in monocytes and macrophages. U937 cells were used to explore the 
underlying nature o f the difference in signalling pathways.
Briefly, in IFN-y primed U937 cells, activation o f FcyRI results in a single calcium spike lasting 
1-2 minutes and activation o f phospholipase D. In cells differentiated with dbcAMP, activation of 
FcyRI results in a prolonged calcium signal caused by the activation o f I crac  and in these cells 
phospholipase C and not phospholipase D is activated by the receptor (Melendez et al, 1998). 
The mechanism underlying this switch in signalling cascades activated by FcyRI was shown to 
result from a switch in the accessory molecule recruited by FcyRI. Thus, in IFN-y primed cells, 
FcyRI recruits the y-chain whereas in dbcAMP differentiated cells, FcyRI recruits FcyRII for signal 
transduction.
FcyRI, FcyRIIa and y-chain are all constitutively expressed on the surface o f U937 cells. However,
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treatment with IFN-y or dbcAMP does alter the levels o f expression. Treatment with IFN-y generates 
a transient 15-fold increase in the levels o f expression o f FcyRI mRNA (Allen and Seed, 1989) 
and a subsequent up regulation in surface-expressed protein. IFN-y also results in an increase in 
expression o f both FcyRIIa (Davis et al, 1994) and y-chain (Ernst et al, 1993) although mRNA levels 
o f both o f these molecules increased by only twofold. Upon treatment with dbcAMP, the level o f 
FcyRI mRNA falls by about 50% although this change is not reflected in the amount o f surface- 
expressed receptor, which is maintained at a steady level (Davis et al, 1994). Levels o f FcyRIIa and 
y-chain mRNA are increased and result in increased surface expression o f both accessory molecules 
(Davis et al, 1994).
It is this change in the relative amounts o f FcyRI, FcyRIIa and y-chain on the cell surface which is 
at the heart o f the switch in cell signalling differentiation causes. Treatment with IFN-y causes a 
differentiation state where FcyRI recruits y-chain exclusively as its accessory signalling molecule, 
whereas treatment with dbcAMP causes FcyRI to recruit and signal through FcyRIIa when it is 
aggregated (Melendez et al, 1998).
Although both FcyRIIa and y-chain both have ITAM motifs, these initiate different signalling 
cascades. With FcyRIIa, a first step in this cascade is the activation o f the phospholipase PIP2-PLC, 
which generates IP3 by cleaving membrane-bound PIP2. The secondary messenger, IP3 then activates 
calcium channels in intracellular stores (IP3 receptor) and the plasma membrane ( I cra c )  resulting 
in a sustained increase in cytosolic calcium levels (Melendez et al, 1998; Davis et al, 1994). A 
y-chain-mediated activation results, in the first instance, in the recruitment and activation o f  the 
phospholipase, PtdCho-PLD. This causes the downstream activation of sphingosine kinase and the 
generation o f a transient calcium signal (Melendez et al, 1998 (2), Davis et al, 1994) observed as 
a single calcium spike lasting 1-2 minutes. The absolute nature o f the switch in FcyRI signalling
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which occurs with differentiation is dramatic and this tight control observed in U937 cells points to 
the potential for very different roles that FcyRI can elicit from a tissue macrophage compared to its 
circulating monocyte precursor.
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1.3 Activation of Macrophages
Macrophages can be generally described as a population o f ubiquitously distributed mononuclear 
phagocytes responsible for numerous homeostatic, immunological, and inflammatory processes. 
Their wide tissue distribution makes these cells ideally suited to provide an immediate defence 
against pathogens prior to a more organised mobilisation o f immune system cells and signals. 
Because macrophages participate in both specific immunity via antigen presentation and cytokine 
production, as well as nonspecific immunity against bacterial, viral, fungal, and cancerous pathogens, 
it is not surprising that macrophages display a wide range o f functional and morphological 
phenotypes.
1.3.1 Macrophage Heterogeneity
Examination o f the body’s macrophages reveals a highly heterogeneous population o f cells which 
can be classified into two broad groups: those found in the bloodstream, which exhibit a more 
monotype-like, undifferentiated nature, which are termed circulating macrophages resident in 
tissues, and those which are generally differentiated and specialised to function in their location in 
tissues, called residential macrophages.
1.3.1.2 Circulatory Macrophages
Circulatory macrophages are young cells but already possess migratory, chemotactic and phagocytic 
activities, as well as Fc gamma receptors expressed in their plasma membranes. Under migration 
into tissues, circulatory macrophages undergo further differentiation (usually lasting at least one day) 
to become multifunctional tissue macrophages. It can be argued that monocytes can be included in
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the circulating macrophage population and should be considered fully functional for their location, 
changing phenotype in response to factors encountered in specific tissue after migration.
1.3.1.2 Residential Macrophages
It has also long been recognized that macrophages isolated from different sites in the body display 
a diversity o f phenotypes and capabilities. Because macrophage function is dependent in part on 
signals received from the immediate tissue microenvironment, it is suggested that macrophage 
heterogeneity may arise from unique conditions within specific tissues. For example, the sterile, 
anaerobic environment o f the spleen or peritoneum will impart different constraints on macrophages 
found there than does the aerobic environment o f the alveolar macrophage, which contains numerous 
external factors. These different constraints produce different phenotypes, illustrated in experiments 
using antibodies directed against specific membrane antigens. For instance, human breast milk 
macrophages express an antigen not observed on monocytes, alveolar macrophages, or peritoneal 
cells. Furthermore, human alveolar macrophage express high levels o f MHC class II antigen, 
whereas the opposite is found for peritoneal macrophages.
1.3.1.3 Generation of Macrophage Heterogeneity
The macrophage population in a particular tissue may be maintained by three mechanisms: influx 
o f monocytes from the circulating blood, local proliferation and biological turnover. Under normal 
steady-state conditions, the renewal o f tissue macrophages occurs through local proliferation o f 
progenitor cells and not via monocyte influx. Originally, it was thought that tissue macrophages 
were long-living cells. More recently, however, it has been shown that depending on the type of 
tissue, their viability ranges between 6 and 16 days. Given this relatively rapid turnover o f cells there
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exists, in a particular locus, a population o f macrophages displaying a spectrum of maturational 
states and an attendant diversity of function.
Because macrophages are responsible for numerous inflammatory processes, it becomes important 
to distinguish between normal or steady state cell turnover and differentiation and induced 
haematopoiesis associated with immunological challenge. Production o f the macrophage lineage 
from bone marrow-derived monocytes is normally controlled by M-CSF, which is constitutively 
produced by many cell types. In response to invasive stimuli and inflammation, monocyte numbers 
increase dramatically, as do serum levels o f M-CSF. In addition, GM-CSF appears in the serum. 
Although there appear to be a large overlap o f macrophage progenitors able to respond to M-CSF 
or GM-CSF, the very different structures and signal transduction mechanisms o f the receptors for 
M-CSF and GM-CSF suggest that the differentiation pathways they initiate, would be dissimilar.
M-CSF-derived macrophages are larger, have a higher phagocytic capacity, and are highly resistant 
to infection by virus compared to GM-CSF-derived macrophages. Conversely, GM-CSF-derived 
macrophages are more cytotoxic against TNF-a-resistant tumour targets and express more MHC 
class II antigen.
The production o f functionally distinct macrophage populations gives the non-specific immune 
system added flexibility to respond to immunological or inflammatory stimuli. It is probable that 
the nature o f an immune response is dictated in large part by the functional phenotypes o f the 
macrophages present within the area o f the immune challenge.
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1.3.2 Macrophage Activation
1.3.2.1 Macrophage Activation is a Two-Stage Process
The term “activated macrophage” is reserved for macrophages possessing specifically increased 
functional activity. The process of activation is not to be confused with differentiation, which is a 
process through which differentiated macrophages acquire only an increase ability to perform specific 
functions. Characteristically, residential tissue macrophages are relatively quiescent immunologically, 
having low oxygen consumption, low levels o f major histocompatibility complex (MHC) class II 
gene expression, and little or no cytokine secretion. Resident macrophages are, however, phagocytic 
and chemotaxic and retain some proliferative capacity.
There are two stages o f macrophage activation, the first being a primed stage in which macrophages 
exhibit enhanced MHC class II expression, antigen presentation, and oxygen consumption, but 
reduced proliferative capacity. The agent that primes macrophages for activation is IFN-y, a product 
o f stimulated T cells. But many other factors, including IFN -a, IFN-p, IL-3, M-CSF, GM-CSF and 
TN F-a can also prime macrophages for selected functions.
Primed macrophages respond to secondary stimuli to become fully activated, a stage defined 
by their inability to proliferate, high oxygen consumption (through NADPH oxidase), killing of 
extracellular and intracellular parasites, tumour cell lysis, and maximal secretion o f mediators of 
inflammation, including TN F-a, IL-1, IL-6, reactive oxygen species, and nitric oxide produced by 
iNOS. Agents capable o f providing secondary signals are diverse and include LPS and antibody- 
associated antigen.
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1.3.3 Cell Surface Receptors M ediate M acrophage Activation
The cell-surface receptors that bind macrophage-activation signals, and as a result initiate intracellular 
signalling cascades, can be divided into two broad groups. Those that mediate activation o f the 
innate immune response include the LPS receptor and the Toll family o f receptors. Receptors that 
initiate and coordinate the specific immune response include Fc receptors (see Section 1.2).
1.3.3.1 The LPS Receptor
Lipopolysaccharide (LPS) is a component o f the cell walls o f Gram-negative bacteria. It is recognised 
by the human immune system as an adjuvant antigen, that is, one that elicits a non-specific response, 
boosting the activity and effectiveness o f the whole immune system. LPS is primarily detected by a 
specific, cell-surface receptor called the LPS receptor (Wright et al. 1990).
The LPS receptor (LPS-R), also known as CD 14 using the CD system o f nomenclature, is a 53 kDa 
protein composed o f 356 amino acids (Bazil et al. 1986). Its mature form requires cleavage o f a 
19-amino acid peptide and N-linked glycosylation at 4 sites on the polypeptide chain. The receptor 
is anchored to the cell surface by linkage to GPI molecule that embeds in the outer o f  the two lipid 
layers that make up the plasma membrane.
LPS-R is strongly expressed on the surface o f monocytes and most tissue macrophages, and to a 
lesser extent on the surface o f granulocytes. It is not expressed on the myeloid progenitor cells that 
mature to these cell types. Expression can also be induced in non-myeloid cell types, including 
hepatocytes and epithelial cell types, upon exposure to LPS.
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As well as the cell-surface expressed form o f the receptor, there are at least two soluble forms of 
LPS-R. Cells shedding the surface-bound receptor, resulting a 48 kDa molecule, produce one form 
(Bazil et al. 1991). The second form o f  soluble receptor is secreted from cells before the addition 
o f the GPI anchor. The soluble LPS receptor is present in whole blood in amounts 100-1000 times 
greater than the membrane-bound receptor.
In binding LPS, the LPS receptor associates with serum protein called LBP (LPS Binding Protein) 
that acts as a lipid transfer enzyme, moving monomers o f LPS to the LPS receptor binding site 
(Hailman et al. 1994). The activation o f the LPS receptor by binding the LPS/LPB complex results in 
the activation o f cells and release o f pro-inflammatory cytokines such as TN F-a. Also up-regulated 
is the expression o f cell adhesion molecules. This allows phagocytic cells such as macrophages to 
directly engage and destroy the bacterial source o f the LPS.
1.3.3.3 The Toll Receptor Family
The Toll receptors (TLRs -  Toll-Like Receptors) are a family of structurally similar cell surface 
receptors that bind a wide range of ligands and initiate key features o f the innate immune response. 
The function o f Toll receptors in the immune response was first discovered in Drosophila (Lemaitre 
et al. 1996) and subsequently an analogue were found and characterised in the mammalian immune 
system (Medzhitov et al. 1997). After this initial discovery came the rapid identification o f several 
additional TLRs within the human genome. Ten TLRs have been found so far, classified as TLR1 
to TLR10.
While individual TLRs bind specifically to one or two ligands, the TLR family as a whole will bind 
a wide range o f microbe-derived ligands. These include LPS and LTA, bound by TLR4, PGN and
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lipoproteins, bound by TLR2, and unmethylated bacterial DNA, bound by TLR9.
The TLR family all share a similar structure. Embedded in the plasma membrane the typical TLR 
possesses a large extracellular portion made up o f between 12 and 23 leucine-rich repeat domains 
with a cysteine-rich domain flanking the transmembrane region. The intracellular portion consists 
o f a Toll/IL-1 receptor homology domain (TIR).
TLR activation leads to an immune response mainly through gene regulation via the NF-kB 
transcription factor system. This TLR-mediated immune response is available to a wide range of 
cell types that form the first line o f defence against an immune challenge. Macrophages, neutrophils 
and dermal, gut and lung epithelial cells all express various TLRs on their surfaces. Upon exposure 
to microbes they are then recruited from the plasma membrane to phagosomes where they help 
facilitate the destruction o f invading cells.
1.3.4 Functions of Activated M acrophages
The central regulatory role that macrophages play in the immune response is reflected in the vast 
array o f substances they can produce. These substances allow such diverse functions as inflammatory 
response initiation and regulation, phagocytosis (see below) and destruction o f microbes and 
reorganisation of tissues (see F igure 1.3.4.1),
1.3.4.1 Phagocytosis and  M icrobicidal Functions
The engulfment of invading bacterial cells and other microbes, a process known as phagocytosis, is 
an essential part o f the immune response as this provides the main mechanism of clearing microbes
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from the body. Macrophages will not only engulf microbial cells, but also possess mechanisms to 
degrade them and process the antigenic markers they carry for presentation to other cells as an 
initiatory step in the specific immune response. The process begins with the macrophage attaching to 
the microbe and then engulfing the cell in an area o f macrophage plasma membrane. This phagosome 
then detaches from the plasma membrane and is held in the cytosol. Organelles called lysosomes 
then fuse with the phagosome. Lysosomes are small endosomes that contain the components o f 
a variety o f cell-killing mechanisms. These include reactive oxygen species (including hydrogen 
peroxide, the superoxide anion and the hydroxyl radical), reactive nitrogen species (including nitric 
oxide) and also oxygen-independent and enzymic mechanisms (including proteases, lysozyme and 
hydrolases). These components are released into the phagosome and proceed to degrade the cell. 
Selected antigen molecules are then taken from the phagosome and displayed in the surface o f the 
macrophage in association with the MHC class II protein. This whole process is summarised in 
Figure 1.3.4.2,
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Tissue Reorganisation
growth factors, Fibroblast growth factor, 
angiogenesis factors, transforming 
growth factors (TGF-a, TGF-M
: ..
Activated Macrophage
Cytotoxicity
Reactive Oxygen Intermediates
(Superoxide, hydrogen peroxide, 
hydroxyl radicals)
Reactive Nitrogen Intermediates
(Nitric oxide, Nitrites, Nitrates)
Oxygen-independent Species
(Neutral proteases, lysozyme, acid 
hydrolases)
„----------------------------------------------------------------------------------------------------------
Inflammation Regulation
Cytokines
(11-1, IL-6, IL-8, TNF-a. IFN-y)
Complement Com ponents
(C1, C4, C2, factors B, D, P)
Protease Inhibitors
{Oj-Macrogobulin, plasmin and 
collagenase inhibitors)
____________
Clotting Factors
(V, VII, IX, X, Prothrombin, 
Plasminogen activator)
Figure 1.3.4.1 M acrophage Function and Molecule Secretion
The vast array of substances an active macrophage can secrete allows it to perform a wide 
range of regulatory and direct functions in the immune response.
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Figure 1.3.4.2 Phagocytosis and D egradation of M icrobial Cells
The phagocytic killing o f microbial cells by macrophages is important as a way of clearing 
invading cells from the host and also in initiating the specific immune response by the 
processing and presentation o f antigen.
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1.4 Regulation of Gene Expression
The central mechanism in the response o f macrophages (and indeed all cells) to stimulus is an 
alteration o f the levels o f gene expression in the nucleus. Gene expression controls the cell at the 
most fundamental level, dictating which functions the cell can perform and how it responds to the 
environment around it.
1.4.1 Strucuture of the Eukaryotic Gene
The control o f expression o f genes in eukaryotic cells is inherently linked to the structures which 
make up the genes themselves. Although a gene, in the form of chromosomal DNA held in the 
nucleus, is a relatively homogenous polymer when compared to the panaromic range o f protein 
structures, the information contained in the nucleotide sequence allows regulation o f its expression 
with a high degree o f control and finesse.
At the most basic level, a gene can be divided into two parts: the part that encodes a protein and 
the part that does not. However, the protein-coding part o f the gene is not a single, unbroken length 
o f DNA. The coding region o f the gene consists o f one or more lengths o f sequence called exons, 
which are interspersed with non-coding sections called introns. The number o f exons can vary 
greatly. The multiple genes encoding the histone proteins that form the chromosomal DNA-protein 
complex contain a single, uninterrupted coding region, as do genes encoding the interferon family 
o f extracellular signalling molecules. In contrast, the coding transcript for an immunoglobulin 
light or heavy chain is made from a large number o f exons, chosen from an even larger selection 
at the locus on the chromosome. Indeed, given the fact that a huge variety o f different proteins 
(immunoglobulins) can be produced from this alternative splicing o f many exons it is perhaps
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inaccurate to describe the exons as belonging to a single gene at all.
The transcription o f an RNA molecule from genomic DNA results in a sequence that incorporates 
both exons and the introns interspersed between them. It is only after this initial transcription step 
that processing occurs to remove the introns and produce a mRNA molecule that can be translated 
into a polypeptide chain by the ribosomal machinery in the cytosol.
Upstream o f the first exon in a gene lies a region o f variable length called the promoter. Within this 
region lie specific lengths o f sequence that can bind to and associate with proteins that control the 
expression o f the gene.
1.4.2 The Promoter Regulates Transcription of the Gene
The gene promoter begins immediately upstream o f the transcription initiation trinucleotide codon 
(usually ATG) and can stretch upstream for many kilobases o f sequence. This large length allows 
multiple protein complexes, including the RNA polymerase complex, to bind and affect expression, 
often in very subtle and complex ways.
One promoter element that is essential for many genes is the so-called TATA box. This is a short 
consensus sequence found approximately 25 nucleotides upstream o f the transcription initiation 
site. It is found in many genes and across many species and is crucial for the correct positioning o f 
the transcriptional apparatus.
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1.4.3 M ultiple Systems C ontrol Gene Expression
The vast number o f extracellular signals a cell can react to are translated, through cell surface 
receptors, to a smaller number o f regulatory systems within the cytosol and nucleus. Through these 
systems, a signal is transduced from the cell surface to the nucleus by a cascade o f molecules, each 
transferring the message to the next. An example o f a system o f great importance in the regulation 
of immune system genes in general and the T N F-a and IL-6 genes in particular is the NF-kB.
1.4.4 The N F-kB Gene Regulation System
1.4.4.1 N F-kB Regulates M any Im m une System Genes
NF-kB (Nuclear Factor Kappa B) is a eukaryotic transcription factor that has been implicated in 
the regulation o f a wide variety o f genes producing cytokines, growth factors and other soluble 
molecules o f the immune system. It was first described as a transcription factor necessary o f the 
transcription o f the gene for the immunoglobulin kappa light chain in B cells, from where it derives 
its name (Sen et al, 1986). NF-kB has since been described in virtually all cell types studied.
1.4.4.2 S truc tu re  of NF-kB
The name NF-kB is used to describe a number o f different proteins. The NF-kB transcription factor 
is a dimer made up o f members o f the rel family o f proteins (See Figure 1.4.4.1), Both hetero- and 
homodimers can be formed. Each o f the rel proteins contains a large, highly conserved domain o f 
300 amino acids, called the rel homology domain or RHD. This domain is responsible for the DNA- 
binding and dimerisation o f the proteins and is also the binding site for an inhibitory protein, IkB,
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which keeps NF-kB in an inactive form in the cytosol (see below). The NF-kB initially described 
as a transcription factor in kappa chain expression in B cells is a dimer o f the p50 and p65 subunits. 
Other combinations produce slight variations in the DNA-binding m otif within the RHD and thus 
results in genes having a preference for one combination o f subunits over another (Kunsch et 
al, 1992). Most o f the combinations o f rel proteins produce NF-kB factors which will activate 
transcription, although several combinations result in transcription repression (Brown et al, 1994).
1.4.4.3 Activation of NF-kB
In it’s resting state, NF-kB sits in the cytosol, bound to IkB. This inhibitory protein masks the 
nuclear localisation signal o f NF-kB and keeps it in the cytoplasm. Like NF-kB, IkB is, in reality, 
a family o f proteins that share structural features. The most obvious o f these are a series o f domain 
repeats, called ankyrin repeats, which vary in number from individual between the IkB proteins. The 
number o f ankyrin repeats affects the specificity o f binding to NF-kB that the inhibitors exhibit.
NF-kB is activated by a wide variety o f signals. These include stress-related species such as reactive 
oxygen intermediates, molecules suggestive o f bacterial infection such as LPS and cytokines such 
as IL-1 and TN F-a. Signals such as these all indicate that tissue damage o f one kind or another has 
occurred and an increase in immune system activity is required. The signal, whatever its source, 
ultimately leads to the activation o f an IkB kinase. This enzyme phophorylates the IkB leading its 
degradation and dissociation from the NF-kB. This then allows the N F-kB to localise to the nucleus 
where it associates with NF-kB binding sites on cell promoters and facilitates upregulation o f gene 
expression.
The genes which NF-kB can bind to and activate are numerous but all many are involved in 
subsequent immune functions, including cell migration and repair (cell adhesion molecules such as
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VCAM-1 and ELAM-1), further activation o f immune cells (cytokines such as IL-1, IL-2, G-CSF 
and TN F-a), inflammation (acute phase response proteins such as angiotensinogen and serum 
amyloid protein) and the regulation o f the NF-kB response itself (IkB proteins). The process o f 
activation is summarised in Figure 1.4.4.2.
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Rel Homology Domain
Relish
Dorsal
p100/p52
p105/p50
Figure 1.4.4.1 The Rel Family of Proteins
The Rel family of proteins form the dimer NF-kB transcription factors. The amino acid 
length o f each protein is displayed at the right hand side and the two black arrows show the 
positions where endoproteolytic cleavage occurs to form the p52 and p50 subunits.
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The activiation of NFkB by multiple signals results in an increase in 
activity of many parts o f the immune system
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2.1 Human Cell Culture
2.1.1 Cell Culture Conditions
The cell type utilised for the work described in this thesis was the U937 cell line, an immortalised, 
human monoblastic cell line which grows in suspension. The cells were grown at 37°C in a water- 
saturated atmosphere containing 6% C 0 2 in air. All cell manipulations were carried out using 
standard aseptic technique in a sterile Class II laminar flow hood. Cells were typically grown in 
cultures o f 10ml in sterile, plastic 50ml flasks, and were spilt 1:2 every fourth day. The medium used 
for cell culture was RPMI 1640 supplemented with 10% fetal calf serum.
2.1.2 Treatment of U937 cells
2.1.2.1 Treatment with IFN-y
Cells were treated with IFN-y to produce an activated monocyte phenotype. A 10ml culture o f cells 
was resuspended in 5ml o f RPMI medium and allowed to recover for 15 minutes. 50pl o f lOOmM 
IFN-y was then added to the culture by pipette and mixed by gentle swirling o f the culture medium 
to give a final concentration o f ImM. The cells were incubated for 3 hours before a further 5ml o f 
RPMI medium was added to the culture and the cells were then left overnight before use.
2.1.2.2 Treatment with dbcAMP
Cells were treated with dibutyryl cyclic AMP (dbcAMP) to differentiate them into a macrophage­
like phenotype. The dbcAMP was stored in a stock solution o f 30mM at -70°C and the required
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final concentration in the culture o f cells was ImM. Therefore, for a 10ml culture 333jil was added 
to give a 1 in 30 dilution. This was done by simply pipetting the dbcAMP into the flask and mixing 
with the medium by gentle swirling. The cells were then incubated for 48 hours before use to allow 
full differentiation to occur.
2.1.3 Transfection and Harvest of U937 Cells
2.1.3.1 Transfection of Cells
Cell cultures were split approximately 18 hours before transfection to ensure a suitable dilution (see 
section 2.1.1). Four hours before transfection the cell density was measured using a haemocytometer. 
For each transfection 3 x 106 cells were transferred ffom the 100ml culture flask to a 60mm plastic 
Petri dish and RPMI medium was added to a final volume of 4ml. These plated cultures were then 
placed back in the 37°C incubator. The plasmid DNA to be transfected was removed from storage 
at -20°C and allowed to thaw on ice. The desired amount o f DNA was then transferred by Gilson 
pipette to a sterile Eppendorf tube and Effectene buffer was added to a total volume o f 150ml. 
8ml o f Enhancer reagent was then added by Gilson pipette and the solution was mixed by vortex 
for 1 second before being incubated at room temperature on the bench top for 3 minutes. 25ml o f 
Effectene transfection reagent was added by pipette and the Eppendorf tube was vortex mixed for 10 
seconds and then incubated at room temperature on the bench top for 7 minutes. The plate o f cells 
was removed from the 37°C incubator and a suitable volume o f RPMI 1640 medium was warmed 
to 37°C. 1ml o f RPMI medium was added to the Eppendorf containing the tranfection reagent/DNA 
solution and was mixed with it by pipetting up and down rapidly but smoothly 5 times. 1ml o f this 
liquid was then taken from the Eppendorf and added drop wise to the plate o f cells, which were 
gently agitated throughout the addition to ensure mixing, thus giving a total volume o f 5mls. The
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plates o f cells were then placed back in the 37°C incubator for the required incubation period
2.1.3.2 Cell Harvest and Lysis (Protocol 1)
Materials: 5x Passive Lysis Buffer (Promega)
A suitable volume o f lx  PLB was prepared by adding volumes o f distilled, autoclaved water to one 
volume o f 5x PLB in a 13ml plastic tube. The resulting lx  PLB was mixed by vigorous shaking 
for several seconds and was then allowed to equilibrate to room temperature on the bench top. The 
previously transfected 5ml cell culture was removed from incubation and spun down to a pellet 
by centrifuge. The supernatant was removed by pouring and inverting the tube on a layer o f tissue 
paper for approximately 15 seconds. 400ml o f lx  PLB was then added to the tube and the pellet 
was disturbed and mixed by pipetting the volume o f lysis buffer up and down several times. The 
lysate was then transferred to a sterilised Eppendorf tube and Luciferase activity was measured 
immediately.
2.1.3.3 Cell Harvest and Lysis (Protocol 2)
This modified protocol was identical to protocol 1, described above, with the exception o f the 
following steps which were performed before the luciferase measurements were taken.
The lysate was transferred to a sterile Eppendorf tube and was incubated at room temperature for 15 
minutes. It was then spun in a bench top microfuge for 30 seconds at 13,000rpm and 4°C to pellet 
cell debris. The cleared supernatant was then transferred to a clean Eppendorf tube and Luciferase 
activity was measured immediately.
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2.2 Bacterial Cell Culture
2.2.1 Cell Culture Conditions
Bacterial cell cultures were used to grow plasmid DNA to provide templates for PCR reactions and 
for transfection into mammalian cells. The strain used in this work was D H 5a. All bacterial cell 
cultures were grown in 5ml (miniprep) or 100ml (maxiprep) volumes o f LB Broth medium, when 
growing in suspension, or on 100mm plates o f LB with Agar when growing colonies on a solid 
medium. Cells on LB Agar plates were grown at 37°C in a normal air atmosphere.
2.2.2 Preparation of Cell Culture Media
2.2.2.1 Preparation of LB Broth Medium
To prepare medium for a 100ml culture of cells, 100ml of distilled water was placed in a 500ml 
conical flask. To this was added 2g of powdered LB. The flask was then stoppered with a piece of 
cotton wool and a aluminium foil cover and autoclaved to sterilise. The medium was then allowed 
to cool before use.
To prepare medium for 5ml miniprep cultures, 100ml o f LB broth was prepared in a Stott-type 
screw-top bottle was used instead o f a conical flask. The medium was then pipetted into sterile 
miniprep tubes under aseptic conditions.
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2.1.2.2 Preparation of LB Agar Plates
400ml o f distilled water was placed in a 500ml Stott bottle. 12.8g o f powdered LB with Agar was 
added and the mixture was autoclaved. The medium was allowed to cool to below 40°C before the 
required antibiotics were added. After gentle mixing by inversion, the medium was poured into 
clean 100mm plastic cell culture plates using standard aseptic techniques. The medium was allowed 
to set before the plates were sealed with Sarin Wrap and stored, inverted, at 4°C.
2.2.2.3 Addition of Antibiotics
Antibiotics were added by pipette before addition o f bacterial cells to liquid broth or pouring o f 
LB Agar plates. The two types used were Ampicillin and Kanamycin. Both were stored in stock 
solutions o f lOOmg/ml at -20°C and were added to a final solution in the medium o f 50|ig/ml.
2.2.3 Transformation of Bacterial Cells
The required number o f 50|il aliquots o f bacterial cells, each in a 1.5ml Eppendorf tube, were taken 
from storage at -70°C and allowed to thaw gently on ice. 2|ig o f DNA was added to each aliquot 
by pipette and mixed with the cells by gentle agitation o f the cells with the pipette tip. The tubes 
were placed on ice for 15 minutes, then heat shocked in a 37°C heat block for 30 seconds and placed 
back on ice for 2 minutes. 500p,l o f LB Broth medium (without antibiotic) was then added to each 
Eppendorf tube and the tubes were incubated at 37°C for 1 hour. 25pl and 100|il from each tube 
were plated out on to LB Agar containing the appropriate antibiotic and when the liquid had been 
absorbed into the medium the plates were inverted and incubated overnight at 37°C.
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2.2.4 Cell Culture Preparations
2.2.4.1 Miniprep Cell Cultures
Miniprep cell cultures were set up to grow plate-grown bacterial colonies in a larger volume of 
liquid medium for extraction o f plasmid DNA and for seeding Maxiprep cultures. 5ml o f LB Broth 
medium, containing the appropriate antibiotic, was added to a sterile glass test tube (with lid) by 
pipette under aseptic conditions. Previously grown colonies were picked from an agar plate with 
sterile plastic pipette tips and one tip was placed in each test tube. The tubes were then incubated at 
37°C overnight in an air incubator while being constantly being agitated in a rotator. Plasmid DNA 
was then harvested from the Miniprep cultures using a Qiagen miniprep kit.
2.2.4.2 Maxiprep Cell Cultures
2ml o f a Miniprep culture was added to 100ml o f LB Broth medium with antibiotics in a conical 
flask. This was then stoppered with a cotton wool plug and incubated overnight at 37°C in a shaking 
incubator. Plasmid DNA was then harvested using a Qiagen Maxiprep kit.
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2.3 DNA Manipulation
2.3.1 Acid Phenol Extraction of Total Cell RNA
Materials: Guanidinium thiocyanate (GTC) buffer:
4M GTC
25mM Sodium citrate 
0.5% Sarcosylic acid 
lOOmM p-Mercaptoethanol 
2M Sodium acetate, pH 4.0 
Phenol (water saturated), pH 4.0 
Chloroform/Isoamyl alcohol (24:1)
Isopropanol 
80% Ethanol 
Nuclease-Free Water
A 10ml culture of U937 cells was resuspended in 500(0.1 o f GTC buffer to lyse the cells. The lysate 
was then transferred to a sterile Eppendorf tube. 50 j l x 1 of 4M Sodium Acetate was added, followed by 
500jil o f Phenol and lOOjol o f Chloroform/Isoamyl alcohol. The tube was securely shut and vortexed 
for several seconds, then placed on ice for 15 minutes. The aqueous and phenol components o f 
the mixture were then separated by centrifuging the tube at 13,000 rpm for 20 minutes. This was 
done at 4°C. The upper aqueous layer containing the RNA was carefully removed by pipette and 
transferred to a new Eppendorf tube. The RNA was precipitated out by the addition o f 500p,l o f 
Isopropanol and collected in a pellet by again centrifuging the tube for 20 minutes (13,000rpm, 4°C). 
The supernatant was poured off and the pellet o f RNA was washed with 500(il o f 80% ethanol. The
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tube was centrifuged again for 5 minutes and the ethanol was carefully removed by pipette. The 
pellet was finally resuspended in 50|l l 1 of nuclease ffee water and stored at -70°C.
2.3.2 Restriction Enzyme Digests
Materials: Restriction Enzyme Buffer (Bohringer Mannheim)
Nuclease-free Water (Promega)
Restriction enzymes were used to cleave plasmid DNA and PCR products at specific sites. 10|il o f 
DNA was placed in a sterile 0.5ml Eppendorf tube. To this was added 2 j l x 1 o f restriction enzyme 
buffer and 6)0.1 nuclease-free water to a total volume o f 18jnl. 2 | l i 1  o f restriction enzyme was then 
added and the reagents were mixed by gently flicking the tube. If  any o f the liquid had been 
displaced to the sides o f the tube they were returned to the bottom by pulse spinning in a desktop 
centrifuge for several seconds. The tube was then incubated at 37°C for 4 hours.
2.3.3 Preparation of cDNA from Total Cell RNA
Materials: Total cell RNA (see 2.3.1)
Sterile Water (Invitrogen)
Oligo dT primer (Invitrogen)
Rnase Inhibitor (Invitrogen)
5x RT Buffer (Invitrogen) 
lOOmM dNTPs (Invitrogen)
80mM Sodium pyrophosphate (Invitrogen)
AMV Reverse Trancriptase (Invitrogen)
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0.5mM EDTA (Invitrogen)
Phenol-Chloroform (Invitrogen)
4M Ammonium acetate (Invitrogen)
100% Ethanol
Nuclease-free water (Promega)
5-10jLtl o f RNA was added to a sterile 0.5ml Eppendorf tube. Sterile water was then added to a final 
volume o f 11 .5|l i 1. 1 j l l I  o f Oligo dT primer was then added and the tube was incubated at 65°C for 10 
minutes to removed any secondary structure in the RNA. The following were then added in order:
lp.1 Rnase Inhibitor
4jj.1 5x RT Buffer
l |il  lOOmM dNTPs
lp.1 80mM Sodium pyrophospate
0.5p.l AMV Reverse Transcriptase
The tube was then incubated at 42°C for 60 minutes followed by 2 minutes at 95°C to denature 
the RNA-cDNA hybrids. The cDNA was then purified by doing an acid phenol extraction. l(il o f 
EDTA and 20jll o f Phenol-Chloroform were added to the tube which was then vortexed for several 
seconds to mix the contents and then spun in a desktop centrifuge at 13,000rpm for 5 minutes. This 
separated the mixture into an upper, aqueous layer and a lower phenol layer. The aqueous layer was 
removed carefully by pipette and transferred into a new sterile Eppendorf tube. 22pl o f Ammonium 
Phospate and 88 p.1 o f Ethanol were then added and the tube was vortexed for several seconds 
before being stored at -70°C overnight to precipitate the cDNA. After thawing the tube was spun at 
13,000rpm and 4°C in a desktop centrifuge for 15 minutes to the pellet the cDNA. The supernatant
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was then removed and the cDNA was resuspended in 50pl o f Nuclease-free water (Promega) and 
stored at -20°C.
2.3.4 Polymerase Chain Reaction
Materials: Sterile Water
lOx Taq Polymerase Buffer (Promega)
25mM Magnesium Chloride (Promega) 
lOOmM dNTPs (Promega)
Oligonucleotide Primers 
Template DNA
Taq thermostable DNA polymerase (Promega)
The Taq Polymerase Buffer, Magnesium Chloride, dNTPs, Primers and template DNA were all 
removed from storage at-20°C  and allowed to thaw on ice. When this was complete each was mixed 
gently by flicking and placed back on ice with the exception o f the magnesium chloride which was 
vortexed for 20 seconds to ensure it was completely dissolved in solution and then placed on ice. 
The substrates were then added to a sterile, 1.5ml Eppendorf tube in the shown above and mixed 
by gentle tapping before the Taq polymerase was removed from storage at -20°C and added to the 
tube. The tube was then placed in the PCR thermocycler and the required program was run. After 
the program was completed the PCR reaction was stored at -20°C until required.
2.3.5 Visualisation on Agarose Gels
Materials: Powdered Agarose
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5 Ox TAE 
Distilled Water 
Ethidium Bromide
2.3.5.1 Preparation of 1-2% Agarose gel (with Ethidium Bromide)
Agarose gel was prepared by first adding 100ml o f distillled water to a 500ml conical flask. 2ml o f 
50x TAE was added to this and mixed by gentle swirling. l-2g o f Agarose was then added depending 
on the percentage gel required. This mixture was gently heating in a microwave oven until the 
agarose had completely melted. After allowing the liquid to cool slightly, 5|il o f Ethidium bromide 
was added and mixed by gently swirling. The mouth o f the flask was then covered with saran wrap, 
allowed to solidify, and kept at room temperature until required.
2.3.5.2 Pouring of Agarose gel
The flask o f agarose gel was heated gently in a microwave oven until liquid and 10ml was removed 
by pipette and placed on a glass slide (6cm by 4cm) which had been previously cleaned with distilled 
water and 70% ethanol. A comb was placed at one end to create wells and the gel was allowed 
to solidfy. The slide and gel were then placed in a gel tank, covered with lx  TAE and allowed to 
equilibrate with the buffer for several minutes.
2.3.5.3 Separation of Nucleic Acids on Agarose Gel
The DNA/RNA samples were then mixed with 3pil o f Orange G running dye and added to the lanes 
by dropwise pipetting and the gel was run at a constant voltage of 75 volts until the dye-front had
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reached the bottom o f the gel. The gel was then removed from the tank and placed on an ultraviolet 
transilluminator and a polaroid o f the fluorescing gel was taken.
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2.4 Luciferase Assays
2.4.1 Single Luciferase Assay
Materials: Lypholised Single Luciferase Assay Reagent (Promega)
Luciferase Assay Reagent Buffer I (Promega)
2.4.1.1 Preparation of Reagents
lx  Luciferase Assay Reagent I (LAR I) was prepared by reconstituting the Single Luciferase Assay 
substrate in 10ml o f buffer. The reagent was mixed thoroughly by inversion and aliquoted into 
lm l volumes in sterile Eppendorf tubes, which were stored at -70°C until used. Approximately 45 
minutes before the assay was performed, the required number o f aliquots o f LAR were removed 
from storage at -70°C and allowed to equilibrate to room temperature on the benchtop. The 
luminometer was also prepared by setting a delay phase o f 2 seconds followed by a measurement 
phase o f 10 seconds.
2.4.1.2 Measurement of Firefly Luciferase Activity
IOOjo.1 of LAR I was pipetted into a clean luminometer tube. 20|il o f cell lysate was added to this 
and mixed by pipetting up and down five times. The tube was then placed in the luminometer and 
the luciferase activity recorded.
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2.4.2 Dual Luciferase Assay
Materials: Luciferase Assay Buffer II (Promega)
Lypholised Luciferase Assay Substrate (Promega)
Stop and Glo™ Buffer (Promega)
Stop and Glo™ Substrate (Promega)
2.4.2.1 Preparation of Reagents
lx  Luciferase Assay Reagent II (LAR II) was prepared by reconstituting the Luciferase Assay 
Substrate in 10ml o f buffer. The reagent was mixed thoroughly by inversion and aliquoted into 1ml 
volumes in sterile Eppendorf tubes, which were stored at -70°C until used. 50x Stop and Glo™ 
reagent was prepared by adding 200jxl o f buffer to'the lypholised substrate. After the substrate had 
been reconstituted by gentle inversion the solution was stored at -70°C until required.
Stop and Glo™ buffer was aliquoted into 1ml volumes in sterile Eppendorf tubes and stored at 
-70°C until required.
Approximately 45 minutes before the assay was performed the required number o f aliquots o f 
LAR and Stop and Glo™ buffer were removed from storage and allowed to equilibrate to room 
temperature on the benchtop. When this has occurred 20|il o f  50x Stop and Glo™ substrate was 
added to each 1ml volume of Stop and Glo™ buffer to give lx  Stop and Glo™ reagent. The 
luminometer was also prepared by setting a delay phase o f 2 seconds followed by a measurement 
phase o f 10 seconds.
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2.4.2.2 M easurement of Firefly and Renilla Luciferase Activities
100(J.l o f LAR was pipetted into a clean luminometer tube. 20(0.1 o f cell lysate was added to this and 
mixed by pipetting up and down five times. The tube was then placed in the luminometer and the 
Firefly Luciferase activity was recorded. The tube then removed from the luminometer and IOOjj.1 o f 
lx  Stop and Glo™ reagent was added and mixed by pipetting up and down 5 times. The tube was 
then placed back in the luminometer and the measurement o f Renilla Luciferase activity was taken.
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3.1 Introduction
M essenger RNA (mRNA) is transcribed from genomic DNA and is the template for protein 
translation. It is a relatively short-lived molecule, only made by the cell when it is required and 
quickly degraded after the appropriate number o f protein molecules has been translated from it. 
Therefore the abundance o f a mRNA molecule, transcribed from a particular gene within a cell, is 
often directly related to the activation state o f the gene and provides a quantifiable way o f measuring 
this activation.
3.1.1 RT-PCR
RT-PCR consists of two separate reactions. The first, the reverse transcription step, uses an enzyme 
derived from the AMV virus called reverse transcriptase. This enzyme synthesises DNA from a 
single-strand RNA template and in the context of the RT reaction synthesises DNA complementary 
to mRNA isolated from cells. This complementary DNA (cDNA) is more stable than RNA as it is 
not susceptible to degradation by the ubiquitous RNase enzymes found on most surfaces and in most 
reagents in a laboratory. The cDNA can also be used as a template for the PCR reaction, which forms 
the second part of the RT-PCR process. Again, this reaction relies on a non-mammalian enzyme, a 
bacteria-derived thermostable DNA polymerase called Taq, which can resist denaturation at the high 
temperatures required to melt DNA strands apart. The Taq enzyme catalyses the extension o f DNA 
in a 5 ’ to 3 ’ direction, using a complementary strand as a template. In the case o f the PCR reaction 
the DNA which is extended is an oligonucleotide primer which anneals to a specific sequence within 
a piece o f DNA. The use o f two o f these primers, one forward and one reverse, allows a short 
sequence within this piece o f DNA to be amplified many times, producing millions o f copies from 
one original.
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3.1.2 Competitive RT-PCR
While RT-PCR is an effective technique for establishing a certain mRNA is expressed in a cell it 
is less useful, in its basic form, for quantifying the amount o f mRNA. The efficiency o f both the 
RT and PCR reactions can vary significantly, so for a given RT-PCR reaction it is not possible to 
deduce the amount o f mRNA initially present from the amount o f DNA that results at the end o f the 
reaction. An internal control is required as a baseline against which the amount o f DNA produced 
in the PCR reaction can be measured. If  this internal control is amplified by the same primers as the 
fragment o f interest then it is possible to quantify the amount o f original mRNA. This the basis for 
competitive PCR, where a fragment is amplified and measured against an internal control competing 
with it for primers.
The work presented in this chapter focuses on attempting to quantify the levels o f T N F -a  and IL-6 
mRNA in stimulated U937 cells using a Competitive RT-PCR assay.
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3.2 Results
3.2.1 Preparation of cDNA
A 10ml culture o f U937 cells was treated overnight with IFN-y and then RNA was extracted from the 
cells using the acid-phenol method. lOp.1 o f this RNA was immediately used to generate cDNA. 10(il 
o f this cDNA and 10(il o f the RNA used to produce it were run on a 2% Agarose gel stained with 
Ethidium Bromide (Figure 3.2.1.1). This showed the RT reaction had generated cDNA molecules 
o f a wide o f sizes, showing up as a continual smear down the gel. The RNA had not been degraded 
substantially by RNase action as the ribosomal 28S and 18S RNA molecules are visible as the two 
significant bands on the gel.
3.2.2 Initial Reactions and Optimisation
3.2.2.1 Positive Control -  FcyRI
To evaluate the PCR reaction at the early stages a positive control, amplifying a portion o f the cDNA 
for FcyRI was used. The primer pair for this produced a fragment o f approximately 300bp in length. 
These primers were then used on two separate templates. The first was the cDNA prepared from 
IFN-y-treated U937 cells and the second was the FcyRI cDNA in a CDM vector backbone. As a 
further control a reaction was carried out which amplified the entire FcyRI cDNA using primers 
specific for sequences in the CDM vector which bordered the cloning site o f the plasmid.
10ml samples of each reaction were run on a 2% agarose gel and the DNA bands were visualised 
with Ethidium bromide under UV light (Figure 3.2.2.1). The gel showed that the PCR reaction had
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produced a clean band o f the correct size from two different preparations o f cDNA (Lanes B and 
C) and also from the FcyRI-CDM vector DNA (Lane D). The full length FcyRI cDNA was also 
synthesised successfully (Lane E). There were no clearly visible non-specific products o f different 
sizes to the predicted products.
3.2.2.2 Sequence Analysis and Primer Design -  TN F-a and IL-6
The sequences for the T N F-a and IL-6 cDNAs were obtained by searching the GENBank database 
(www.ncbi.nih.org) . The 3 ’-untranslated regions o f the mRNA were identified and complementary 
oligonucleotides were designed for fragments within this region (see Figure 3.2.2.2). Primers were 
designed to incorporate the following characteristics:
• 20-25 nucleotides in length
• Approximately 50% G/C content
• Terminal nucleotides either G or C
• Lack o f repeated nucleotides (e.g. AAAA)
The desired size of the PCR product to be produced was between 300 and 500 base pairs. This 
would produce a fragment which could be easily visualised on an agarose gel while remaining 
small enough to give a relatively straightforward PCR reaction. The pair of primers for each cDNA 
consisted of a forward primer which would anneal to the anti-sense strand of cDNA and a be 
extended in the same direction as the reading frame to produce the coding strand, and a reverse 
primer which would anneal to the sense strand and be extended to produce the antisense strand of 
the fragment. The primer characteristics are summarised in table 3.2.2.2 below.
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Table 3.2.2.2
cDNA Forward Primer Reverse Primer Fragment Size
TNF-a CTT AGG CCT TCC TCT CTC CAG ATG
CCG ATT ACA GAC 
ACA ACT CCC 395bp
:
IL-6
GTT AAT GGG CAT TCC 
TTC TTC TGG
GAG GTA AAG CCT 
ACA CTT TCC AAG 298bp
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1000bp
500bp
Figure 3.2.1.1 P repara tion  of cDNA
Lane B shows cDNA prepared by reverse 
transcription from the total cell RNA shown in 
Lane C. Lane A contains lkb DNA ladder 
markers.
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1OOObp
500bp
Figure 3.2.2.1 PCR Postive C ontrol - FcyRI
PCR reaction positive control using internal to primers to 
FcyRI with cDNA prepared from IFN-y-treated U937 cells 
(Lanes B,C), FcyRI cDNA in CDM vector (Lane D) and 
external primers with FcyRI cDNA in CDM vector (Lane E). 
Markers (Lane A) are lkb DNA ladder.
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5' Untranslated Region 3' Untranslated Region
mRNA
(single-stranded)
5' Cap i
polyA tail
(approx. 200 residues)
Protein Encoding 
Region
Reverse Transcription
cDNA
(singie-siranded)
R e v erse
Prim er
cDNA 5'
(double-stranded) 3 '
Forw ard
Prim er
R e v erse
Prim er
Figure 3.2.2.2 Structures of mRNA and cDNA molecules
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3.2.2.3 Initial PCR reaction - TN F-a and IL-6
A 35 cycle PCR reaction was run using the primer pairs for T N Fa and IL-6 against two preparations 
o f cDNA from IFN-y-treated U937 cells. A reaction using the forward and reverse external CDM 
primers against FcyRI-CDM was used as a positive control. 10ml samples were run on a 2% agarose 
gel and visualised with ethidium bromide under UV light (Figure 3.2.2.3), The reactions using the 
T N F-a primers produced a product o f the predicted size o f just under 400bp, but also a number 
o f non-specific products at sizes smaller than this. The reactions using the IL-6 primer pair also 
produced the predicted fragment as well as several non-specific products. It was likely that this was 
due to the relatively low annealing temperature o f 50°C and that the reaction had to be optimised for 
annealing temperature to produce a specific amplification.
3.2.2.4 Optimisation of Annealing Temperature -  TN F-a and IL-6
A series o f 35 cycle PCR reactions were carried out where the annealing temperature was set at 
52.5°C, 55°C, 57.5°C and 60°C. This series was done using both sets o f primer pairs with the cDNA 
described previously. 10ml samples were then run on a 1% agarose gel (Figure 3.2.2.4). Both 
the TN F-a and IL-6 primers produced correct-sized fragments. The number o f other non-specific 
products diminished and the amount o f the specific product increased as the annealing temperature 
rose. From these results, an annealing temperature o f 57.5°C was chosen as the preferred annealing 
temperature for all future reactions using these primers.
3.2.2.5 Optimisation of Cycle Number -  TN F-a and IL-6
PCR reactions were carried out at a range o f cycle numbers (15, 20, 25, 30, 35, 40) using either
Chapter 3: Competitive RT-PCR
the T N F-a or IL-6 forward/reverse primer pairs. Melting, annealing and extension temperatures 
during the cycle phase o f the reaction were 93°C, 57.5°C and 72°C respectively. 1 OjllI samples of 
each reaction were run and visualised on 2% agarose gels (Figure 3.2.2.5 (TNF-a) and Figure
3.2.2.6 (IL-6)). The results were similar for both the TN F-a and IL-6 reactions. In each case there 
was no visible product at 15 and 20 reaction cycles. A product band appeared at 25 cycles and this 
increased in intensity as the number o f cycles was increased to 40.
3.2.2.6 Optimisation of Magnesium Concentration -  TN F-a and IL-6
Magnesium is an essential cofactor o f the Taq polymerase enzyme and therefore variations in the 
concentration o f Mg2+ ions in the PCR reaction may have a profound effect on the efficiency o f the 
reaction. Previous reactions had magnesium chloride added to a final concentration o f 1.5mM. This 
produced a successful reaction but it was necessary to investigate whether this was producing the 
best possible results or if  a slight change in the amount o f magnesium added would result in a vast 
change in reaction efficiency; a possibility given the small volumes being pipetted. 35 cycle PCR 
reactions were run using either the T N F-a or IL-6 primer pairs and with magnesium added at final 
concentrations o f ImM, 1.5mM and 2mM. 10|il samples from each reaction were run and visualised 
on 2% agarose gels (Figure 3.2.2.7). In both reaction series all 3 concentrations o f magnesium 
gave a positive result although the amount o f specific product was reduced when the magnesium 
concentration was higher.
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1OOObp 
500bp —
Figure 3.2.2.3 PC R  Reaction - T N F-a, IL-6
PCR reaction using INF-y-treated U937 with T N F-a 
forward/reverse primer pair (Lanes B and C) and IL-6 
forward/reverse primer pair (Lanes D and E). Positive 
control (Lane F) was CDM external forward/reverse 
primers with FcyRI-CDM plasmid DNA. Markers (Lane 
A) were 1 kb DNA ladder.
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1000bp
500bp—
Figure 3.2.2.4 O ptim isation of Annealing Tem perature
PCR reactions were performed with temperatures for the annealing 
phase of the cycle set at 52.5°C, 55°C, 57.5°C and 60°C using the 
TN F-a primer pair (Lanes B-E) and the IL-6 primer pair (Lanes F-I). 
Lane A contains lkb DNA ladder markers.
Chapter 3: Competitive RT-PCR
A B C D E F G
Figure 3.2.2.5 O ptim isation of Cycle N um ber - TNF- a
PCR reactions were run at 15 cycles (Lane B), 20 cycles (Lane 
C), 25 cycles (Lane D), 30 cycles (Lane E), 35 cycles (Lane F) 
and 40 cycles (Lane G) using IFN-y-treated U937 cell cDNA and 
TN F-a primers. Lane A contains lkb DNA ladder markers.
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10OObp - 
500bp—
Figure 3.2.2.6 O ptim isation of Cycle N um ber - IL-6
PCR reactions were run at 15 cycles (Lane B), 20 cycles (Lane C), 25 
cycles (Lane D), 30 cycles (Lane E), 35 cycles (Lane F) and 40 cycles 
(Lane G) using IFN-y-treated U937 cell cDNA and IL-6 primers. 
Lane A contains lkb DNA ladder markers.
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A B C D E
(A)
500bp -
A B C D E
(B)
500bp -
Figure 32.2.1  O ptim isation of M agnesium  C oncentration
PCR reactions were performed using IFN-y-treated U937 
cDNA using T N F-a (A) and IL-6 (B) primers. Magnesium 
concentration was 2mM (Lane B), 1.5mM (Lane C) and ImM 
(Lane D). Lane A contains the lkb DNA ladder markers and 
Lane E contains the FcyRI positive control.
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3.2.3 Restriction Enzyme Digests of PCR products
To confirm that the PCR products were the predicted TN F-a and IL-6 fragments multiple restriction 
enzyme digests were carried out on each fragment.
3.2.3.1 Selection of Restriction Enzymes
Restriction maps showing the restriction enzyme cut sites in the sequence o f the TN F-a and IL-6 
fragments were generated using the GCG computer software package. This was used to select the 
enzymes with which to digest each fragment. The enzyme picked and the predicted fragments they 
would produce are summarised in Figure 3.2.3.I.
3.2.3.2 Restriction Digests of PCR Fragments
The putative T N F-a and IL-6 fragments were digested by the enzymes described above according 
to the protocol described in section 2.3.2. lOjil aliquots o f the reactions were run and visualised 
on 2% agarose gels (Figures 3.2.3.2 and 3.2.3.3), The fragments generated in each case were as 
predicted in the restriction maps and therefore it was concluded that the two fragments observed 
were amplified from the 3 ’ untranslated regions o f the TN F-a and IL-6 mRNAs.
3.2.4 Subcloning of PCR Fragments in pCR2.1 Plasmid Vector
PCR-generated fragments of DNA were subcloned into the pCR2.1 vector for use in generating 
the deleted versions of the fragments to be used in the competitive PCR reactions. The subcloning 
reaction was performed using DNA taken directly from the PCR reaction tube after a fraction of this
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had been analysed on an agarose gel to ensure there were no non-specific products. The protocol 
was as described in section 2.2.5. Bacterial colonies were selected to inoculate miniprep cultures 
and plasmid DNA was prepared from these. A restriction digest was performed using the enzyme 
EcoRI, which excises any DNA inserted into the pCR2.1 plasmid. A fraction of the digest was run 
on an agarose gel to visualise the plasmid DNA and any inserts. Figures 3.2.4.1 and 3.2.4.2 show 
visualisation o f digests o f plasmid DNA which did contain the T N F-a and IL-6 PCR fragments 
inserted at the multiple cloning site. The gel for the T N F-a minipreps (Figure 3.2.4.1) shows inserts 
o f approximately 400bp in lanes I and K while the gel for the IL-6 minipreps (Figure 3.2.4.2) shows 
an insert o f approximately 300bp in lane K. The plasmids were amplified by Maxiprep and the 
plasmid DNA was stored at -20°C until required.
3.2.5 Generation of Deletion Constructs
3.2.5.1 Overview of the Protocol
A PCR protocol was devised to generate a forms o f the T N F-a and IL-6 PCR fragments which 
had a central portion o f their sequence deleted. The undeleted form o f the fragment was used as a 
template and two separate reactions were carried out with this. The first utilised the original Forward 
primer and a reverse primer which would anneal to sequence within the fragment, rather than at the 
end. This primer also featured a sequence o f 10 nucleotides at its 5 ’end which did not anneal to 
the template. The second reaction used the original Reverse primer and an internal forward primer 
with series o f 10 nucleotides at its 5’ end complementary to the overhanging 10 nucleotides on the 
internal reverse primer.
These two reactions generated two PCR products, which were only part of the original template. The
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first was analogous to the beginning o f the original template with the addition o f the 10-nucleotide 
overhang at the end. The second was analogous the end o f the original template, this time with the 
10 nucleotide overhang at the beginning o f the fragment. The middle portion o f the original template 
sequence was not found in either o f the two daughter products.
To join these two fragments together, thus generating a form o f the original fragment with a length o f 
its sequence deleted, a third reaction was performed using both daughter fragments as template and 
the original Forward and Reverse primers. The 10-nucleotide complementary sequences allowed 
single strands from each fragment to anneal togther and be extended, creating a single, complete 
fragment. The three reactions described above are summarised in Figure 3.2.5.I.
3.2.5.2 Design of Internal primers
The sequence o f the T N F-a and IL-6 PCR fragments were analysed and internal primers were 
designed following the criteria previously described (see Section 3.2.1). The primers and the 
fragments they will generate are shown in Figures 3.2.5.2 A and B.
3.2.5.3 PCR Reactions and Subcloning of Fragments
Following the 3-reaction protocol described above, fragments were generated using the combination 
of original terminal and internal primer pairs for both the TN F-a and IL-6 PCR fragments. The 
separate fragment were generated first (Figure 3.2.5.3) and then combined to produce the deleted 
versions o f the T N F-a and IL-6 PCR (hereafter called ATNF-a and AIL-6) fragments (Figure 
3.2.5.4). The AIL-6 fragment was present in similar quantities to both the undeleted fragments 
which were generated as positive controls in parallel. The ATNF-a fragment was present in much
Chapter 3: Competitive RT-PCR
lower quantities but was visible. It was therefore purified from the gel before both fragments were 
subcloned into the vector pCR2.1 and plasmid DNA minipreps were prepared for each putative 
construct. The EcoRI digests o f these minipreps are shown in Figure 3.2.5.5. Inserts o f the correct 
size were present in one o f the ATNF-a constructs (Lane D) and in two o f the AIL-6 (Lanes H 
and K). These plasmids were used to make The plasmids were then amplified by Maxiprep and the 
plasmid DNA was stored at -20°C until required.
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TNF-a Fragments
Uncut 1 I
394
Alu 1 1 II 11 I
72 117 205
Ban 11 1 II I
51 343
Nco 1 i u r - I
61 333
Ava II I II I
174 220
Hae III 11 If I
5 256 98 35
IL-6 Fragments
Uncut I
297
Alu 1 I II I
Vsp 1
157 140
II I
177 120
Dra 1 I II I
Rsa 1
169 128
II I
182 115
Figure 3.2.3.1 R estriction Enzyme Digest M aps
Sequence analysis predicted the following restriction enzyme 
digest products when the TN F-a and IL-6 PCR fragments were 
digested with the enzymes listed. The digest products are shown in 
the order in which they are found moving along the sense strand of 
the fragment in a 5' to 3' direction.The units o f length shown are 
base pairs.
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A B C D E F G
500bp—
400bp
300bp-
2 0 0 bp
1 0 0 bp
Figure 3.2.3.2 Restriction Digests of T N F -a  PC R  Fragm ent
Lanes C to G show restriction digest products using the 
following restriction enzymes: Alu I (Lane C), Ban II (Lane D, 
Nco I (Lane E), Ava II (Lane F) and Hae III (Lane G). Lane B 
contains undigested TN F-a fragment and Lane A contains 
lOObp DNA ladder markers.
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A B C D E F
500bp
400bp
300bp
200bp
100bp
Figure 3.2.3.3 Restriction Digests of IL-6 PCR Fragm ent
Lanes C to F show restriction digests o f the IL-6 PCR 
fragment with the following restriction enzymes: Alu I (Lane 
C), Vsp 1 (Lane D), Dra I (Lane E) and Rsa I (Lane F). Lane 
B contains uncut IL-6 PCR fragment and Lane A contains 
1 OObp DNA ladder markers.
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A B C D E F G H  I J K
1000bp - 
500bp—
Figure 3.2.4.1 T N F -a  M iniprep Digests
Lanes B-K show five plasmid DNA minipreps uncut and cut with EcoRI (Miniprep 1 
is shown uncut in Lane B and cut in Lane C, etc.). Lane A contains lkb DNA ladder 
markers.
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A B C D E F G H  I J K
1 0 0 0 bp
Figure 3.2.4.2 IL-6 M iniprep Digests
Lanes B-K show five plasmid DNA minipreps uncut and cut with EcoRI (Miniprep 1 
is shown uncut in Lane B and cut in Lane C, etc.). Lane A contains lkb DNA ladder 
markers.
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( f m
Original PCR Fragment
V V
PCR Reaction 1 PCR Reaction 2
-
V
In te rn a l p rim er w ith o v e rh a n g  
a n n e a ls  to te m p la te  s tra n d  an d  is 
e x ten d ed  in 5* to  3‘ d irection by Taq 
po lym erase . v
V
Term inal prim er a n n e a ls  to new  P C R  
p roduc t a n d  is e x ten d ed  in 5' to 3' 
d irection by Taq po lym erase . V
V
D oub le  s t ra n d e d  P C R  p ro d u c t is 
copy  of th e  te rm in a l 5 ‘ te rm ina l 
reg io n  of th e  orig inal tem p la te  
s tran d .
V
PCR Reaction 3
V
O v e rh a n g s  allow  DNA from P C R  
reac tio n s  1 a n d  2 to  a n n e a l.  Both 
s tra n d s  a re  th en  e x te n d e d  to form 
v ersion  of o riginal d o u b le -s tra n d e d  
tem p la te  with m iddle  reg ion  de le ted . 
Term inal F o rw ard  a n d  R e v e rse  
p rim ers amplify th is new  tem plate .
Deleted form of PCR Fragment
Figure 3.2.5.1 G eneration of PCR Fragm ent with In ternal Deletions
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Forward 2 Primer 5' CCTAGCTAG GGCTGAACAATAG I 3'
Overhang Sequence Specific
Reverse 2 Primer 5' CTAGCTAGG fp 3'
Overhang Sequence Specific
Original Fragment (397bp)
5' Fragment 
(109bp)
3' Fragment 
(177bp)
Deleted Form of Fragment (277bp)
Figure 3.2.5.2 (A) T N F -a  In ternal P rim ers and Deletion Fragm ent
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Forward 2 Primer
Overhang Sequence Specific
Reverse 2 Primer 5' CGATCGATCC 'iGJC CTCA1 3'
Overhang Sequence Specific
Original Fragment (295bp)
5' Fragment 
(105bp)
3' Fragment 
(130bp)
Deleted Form of Fragment (225bp)
Figure 3.2.5.2 (B) IL-6 In ternal P rim ers and Deletion Fragm ent
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B D H
50 0 b p -
400bp
300bp
200bp
100bp
Figure 3.2.5.3 In ternal PCR Reactions
Four fragments were generated using terminal and internal primers and purified TNF- 
a  and IL-6 PCR fragments as the template molecules. The reaction products are 
visualised above, together with positives controls.
Lanes A and F contain lOObp DNA ladder markers. Lanes B and E contain original IL- 
6 fragment postives controls, B using purified IL-6 fragment as a template and E using 
IFN-y-treated U937 cell cDNA as a template. Lane C contains the 5' IL-6 fragment 
(105bp). Lane G contains the 3' IL-6 fragment (130bp). Lane H contains the 3' TN F-a 
fragment (177bp). Lane I contains the 5' TN F-a fragment (109bp). Lane J contains an 
original TN F-a fragment postitive control using IFN-y-treated U937 cell cDNA as a 
template.
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Figure 3.2.5.4 Deletion PCR Fragm ents
Deleted PCR fragments were generated by 
annealation and extension of previously generated 
terminal fragments. Lane B shows the deleted 
form of the TN F-a fragment (277bp), compared 
with the original length fragment (397bp) in Lane 
D. Lane C shows the deleted form of the IL-6 
fragment (225bp) compared with the original 
length fragment (295bp) in Lane E.
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Figure 3.2.5.5 ATNF-a/AIL-6 Fragm ent-pC R2.1 M inipreps
Plasmid miniprep DNA was digested with EcoRI. Lanes B-F show five ATNF-a 
minipreps and Lanes G-K show five AIL-6 minipreps.
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3.2.6 Competitive PCR Reactions
To test whether accurate measurements of mRNA were possible using a PCR system with a 
competitive template, reactions were performed using known amounts of the original and deleted 
PCR fragments in the form of the plasmids previously constructed. These reactions would show if a 
relative amount of each construct would generate a relative difference in band intensities.
3.2.6.1 Single Template Reactions
Each plasmid construct was used as the single template in four separate PCR reactions to evaluate 
each one individually. The reactions were 35 cycles in length and the annealing temperature used 
was 55°C. Purified T N F-a and IL-6 PCR fragments were used as positive controls. The results 
are shown in Figure 3.2.6.I. Both the T N F-a plasmids produced very strong, clean bands o f the 
correct size. The plasmid carrying the undeleted form o f the IL-6 fragment also produced a strong, 
clean band o f the correct size, but the plasmid carrying the deleted form did not produce any 
visible product at all. Subsequent attempts to generate a product with this plasmid, under a number 
o f different conditions, all failed and so only the pair o f TN F-a plasmid were used in further 
competitive PCR reactions.
3.2.6.2 Competitive Reaction 1
A series o f four reactions were performed in which the amounts o f two plasmids were varied by 
a thousand fold in opposite directions. This was to establish a general idea o f the amount o f PCR 
product the plasmids would generate relative to each other. The amount o f DNA used was l-1000pg. 
The results are shown in Figure 3.2.6.2. With an initial amount o f lOOOpg, the T N F-a construct
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generated a large amount o f product, but when the initial amount was dropped to lOOpg the amount 
o f product decreased substantially. At an initial amount o f lOOpg the product was no longer visible 
on the gel. The ATNF-a construct did not produce any visible product when lpg was used as the 
initial template, but when this amount was increased to lOpg the amount o f product the reaction 
gave was comparable to that produced by lOOOpg o f the T N F-a construct. The amount o f product 
remained at this level as the amount o f ATNF-a plasmid was increased to 100 and lOOOpg.
3.2.6.3 Com petitive Reaction 2
To establish whether the rapid decrease in product from theTN F-a was due to competition from the 
ATNF-a construct the TN F-a construct was kept constant at lOOpg while the ATNF-a construct was 
increased from lpg to 50pg. The results o f the reaction are shown in F igure 3.2.6.3, The gel showed 
a smooth increase the amount o f ATNF-a product as the initial amount o f plasmid increased and 
a corresponding decrease in the amount o f product from the T N F-a plasmid. This showed that the 
reaction off the TN F-a construct was being limited in some way, as a constant amount o f template 
should have given a constant amount o f product.
3.2.6.4 M athem atical M odel of PC R Reaction -  P rim er C oncentration
The most likely candidate for a limiting reagent was the primer pair. To establish whether this was 
the case, a mathematical model o f the primer concentration over time was constructed. The details 
o f the calculations and the resultant data are shown below in Figure 3.2.6.4, and analysed in greater 
detail in the discussion section of this chapter (Section 3.3). The data suggested that the lack of 
primers would limit the amount o f one o f the products (in this case the T N F-a product) if  the 
initial amount o f was significantly less than the initial amount o f competing template (the ATNF-a
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plasmid). The plasmid preps were analysed by spectrophotometry and it was found that the T N F-a 
concentration was nearly a thousand-fold less than previously thought. Therefore, new preparations 
o f each plasmid were prepared and subject to multiple spectrophotometric measurements to ensure 
that the concentrations o f each were comparable.
3.2.6.5 Com petitive Reaction 3
A series o f reactions were performed where the initial amount o f T N F-a plasmid was decreased from 
50-lpg and the initial amount o f the ATNF-a plasmid was increased from l-50pg. The results are 
shown in F igure 3.2.6.5. The TN F-a product showed a smooth decrease as the initial concentration 
was reduced and the ATNF-a product showed a smooth increase as the initial concentration was 
increased. The crossover point, where the amount o f product from each template were equal occurred 
at between 20pg and 30pg for both plasmids, suggesting that the plasmids would produce equal 
amounts o f product under equal reaction conditions and therefore one could be used to quantitate 
the amount o f the other present in a sample.
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Figure 3.2.6.1 Plasmid C ontruct Test Reactions
Lanes B and C show 35 cycle PCR reactions using the deleted 
and undeleted TN F-a plasmid constructs respectively. Lane D 
hows an identical control reaction using purified T N F-a 
fragment as template. Lanes E and F show reactions using the 
IL-6 deleted and undeleted plasmid constructs with an IL-6 
postitive control, using purified IL-6 fragment DNA as the 
template. Lane A contains a lOObp DNA marker ladder.
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Figure 3.2.6.2 Com petitive PCR Reaction 1
Lanes B to E show the results o f a series o f four 
competitive PCR reactions using the deleted and 
undeleted T N F-a fragment plasm id constructs as 
templates. Lane B shows lOOOpg of undeleted plasmid vs. 
lpg of deleted plasmid. Lane C shows lOOpg undeleted 
vs. lOpg deleted plasmid. Lane D shows lOpg undeleted 
vs. lOOpg deleted plasmid. Lane E shows lpg undeleted 
vs. lOOOpg deleted plasmid. Lane F shows the purified, 
400bp TN F-a positive control and Lane A contains lOObp 
DNA ladder markers.
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500bp
mmmm m **#  : *
Figure 3.2.6.3 Com petitive PC R Reaction 2
Lanes B to G show a competitive PCR reaction series where the 
undeleted plasmid template (upper band) was kept constant at lOOpg and 
the deleted plasmid (lower band) was varied from lpg to 50 pg (1, 10, 
20, 30, 40, 50pg) from lane B to lane G. Lane H contains the TN F-a 
postiive control and Lane A contains lOObp DNA ladder markers.
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To determine whether the amount of primer was a limiting factor in the PCR reaction, the amounts 
of PCR product generated and primers consumed throughout the reaction were calculated:
The reaction modelled was one where no pCR2.1-ATNF-ocF plasmid was present and the initial 
amount of pCR2.1-TNF-aF was lOOpg. The reaction was 25 cycles long.
pCR2.1-TNF-aF Plasmid = 4300 base pairs
Molecular Weight of pCR2.1-TNF-ocF Plasmid = 4300 bases x 650Da per base
= 2795kDa
So, 1 mole of pCR2.1-TNF-aF Plasmid = 2,795,000g
There are lOOpg of plasmid in the reaction
1 0 0 x l0 '12g
Therefore, the number of moles of plasmid = -------------------   3.58x10' moles
2795000g
This is effectively the amount of PCR product at cycles = 0. The first cycle of the reaction will 
double this amount as each plasmid acts as a template for the generation of one double-stranded 
product molecule. With each subsequent cycle the amount of PCR product will double again. This 
is shown in Table 4.2.6.4.
This shows that after 25 cycles this PCR reaction generates 1.2 nanomoles of TNF-aF.
Each individual PCR reaction requires 1 molecule of template DNA and 1 pair of primers (1 
forward and 1 reverse)
So, 1 mole of template needs 1 mole of primers
Therefore the number of moles of primer used up during a reaction cycle is equal to the number of 
new moles of product generated in that cycle (see Table 3.2.6.4, Column 2)
The concentration of the stock mix of Primers was 27.86|iM. The volume in each reaction was 
1 (j.1, therefore the initial amount of Primers in each reaction was:
27.86p,M x 1 x 10'6L = 27.86 pmoles
Figure 3.2.6.4 Mathematical Modelling of Primer Consumption in PCR Reactions
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The number of Primer pairs used in each cycle of the reaction will equal the number of new PCR 
products generated in that cycle, and, assuming a reaction in which all available templates are used, 
that number will be equal the total amount of PCR product in the previous reaction.
Therefore the consumption of Primers during the course of reaction can be calculated and is shown 
in Column 3 of Table 4.2.6.4, below.
able 3.2.6.4 
Cycle Number Amount of PCR Product (moles)
Amount of Primer 
Pair (moles)
0 3.58 x 10 '17 2.786 x 1 0 11
1 7.16 x 10‘17 2.786 x 10 ’11
2 1.43 x 10 '16 2.786 x 10‘11
3 2.86 x 10"16 2.786 x 10 '11
4 5.73 x 10 '16 2.786 x 10 '11
5 1.15 x 1 0 '15 2.786 x 10 ‘11
6 2.3 x 1 0 15 2.786 x 10’11
7 4.6 x 10’15 2.7855 x 10 '11
8 9.2 x 10 '15 2.8651 x 10 '11
9 1.84 x 10‘14 2.7842 x 10 ‘11
10 3.68 x 10’14 2.7822 x 10 '11
11 7.33 x 10 '14 2.7786 x 10‘11
12 1.47 x 10 '13 2.7713 x 10 '11
13 2.93 x 10 '13 2.7566 x 1 0 '11
14 5.86 x 10 '13 2.7273 x 10~11
15 1.17 x 10 '12 2.6687 x 10 '11
16 2.34 x 10 '12 2.5517 x 10 '11
17 4.69 x 10 '12 2.3177 x 10 '11
18 9.38 x 10‘12 1.8487 x 10 ‘11
19 1.88 x 10 '11 9.1071 x 10’12
20 3.75 x 10 '11 0
21 7.51 x 10 '11 0
22 1.5 x 10 '10 0
23 3.0 x 10’10 o •
24 6. 0 x 10 '10 0
25 1.2 x 10’9 0
Figure 3.2.6.4 (continued)
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*
___
Primer Pair 
PCR Product
The results are shown below in graphical form
1 x10'8
1 x10’9
1 x 1 0 ’10
1 x 1 0 ‘11
10 _0>
o
2
>♦- o
6 z
1 x 1 0 ’14
1 x 1 0 '12 
1 x 1 0 '13
1 x 1 0 ’15
1 x 1 0 '16
These results show that this PCR reaction will run out of primers before the 20th cycle has been 
reached.
10 15 20 25
Cycle Number
1 x 1 0 '170
Figure 3.2.6.4 (continued)
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Figure 3.2.6.5 Com petitive PCR Reaction 3
A series o f competitive reactions were performed in which both the 
undeleted and deleted plasmids were varied. The undeleted plasmid was 
decreased from lane B to lane G (50, 40, 30, 20, 10, lpg) and the deleted 
plasmid was increased from lane B to lane G (1, 10, 20, 30, 40, 50pg). 
Lane H contains the TN F-a positive control and lane A contains lOObp 
DNA ladder markers.
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3.3 Discussion
The purpose o f the work described in this chapter was to develop an assay which could be used 
to investigate the activation states o f a number o f genes under a number o f conditions. While this 
investigation was not reached the work which preceded it did give valuable insights into the process 
o f assay development and the specific methodologies involved.
The process involved the establishment o f the PCR reaction as a reproducible and consistent assay 
method, and the construction o f plasmids to act as internal controls against which cell-derived 
genetic signals could be quantified.
3.3.1 Primer Design and PCR Reaction Optimisation
It was decided to design the primer pairs required for the PCR reaction on paper and not to use a 
sequence analysing computer program. The expression o f TN F-a, IL-6 and IL-10 has been widely 
reported in U937 cells and similar cell types, so it was thought likely that finding a signal, under 
the right conditions, would be relatively straight forward given the levels o f expression previously 
described and the central role these cytokines play in the operation o f macrophages and monocytes. 
There were five criteria used to limit the choice o f primer sites. The first four are listed in section 
3.2.2.2, The length o f the primer, the first o f these criteria was important in striking a balance 
between an oligonucleotide which would possess a high degree o f specificity for a particular 
sequence (necessary when seeking to amplify one mRNA signal out many thousands) and one 
which would rapidly anneal to the template molecule during the limited time allowed for this in the 
annealation phase o f the PCR cycle. In practice the primers designed and used varied between 24 
and 30 nucleotides. This variation was to comply as much as possible with the other three criteria.
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The fifth criterion was the length o f the fragment o f DNA the primer pair would generate. A length 
o f several hundred bases would ensure that the fragment was large enough to be visible when run 
on an ethidium-stained agarose gel, but would also avoid the problems associated with amplifying 
lengthier pieces o f DNA (e.g. secondary structures in the template molecule).
The PCR reaction shown in Figure 3.2.2.3 was the first reaction performed using the primers and 
using two separate preparations o f U937 cDNA. Its success, and the success o f the reactions which 
followed, showed that this simple method o f primer design was robust enough for the types o f PCR 
used in this work.
The optimisation o f the reaction involved analysing the effect o f factors such as cycle number, 
annealing temperature and reagent concentration on the reaction, both in terms o f product quantity 
and specificity.
3.3.2 Development of the T N F -a  Com petitive PC R  Assay
The generation of the internal control for the TN F-a PCR reaction was achieved using internal 
PCR primers, again designed on paper, in a series o f reactions to create the ends o f the PCR 
product, excluding the middle region, and anneal these together. These deleted fragments were then 
subcloned into the pCR2.1 vector to create the undeleted and deleted template constructs.
These plasmids were then used to determine whether two templates which used the same primers 
but generated different products could be used in one reaction to generate products the amounts o f 
which accurately reflected the initial amounts o f template.
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The first reaction (Figure 3.2.6.2) showed that the plasmid templates were not behaving as had been 
predicted. The rapid decrease in the amount o f TN F-aF being produced from the pCR2.1 -TN F-a 
plasmid when a comparatively small amount o f the pCR2.1-ATNF-a plasmid was added suggested 
that a reagent was not available in excess and thereby limited the production o f the TN F-aF to 
the extent that it was not visible when run on the agarose gel stained with ethidium bromide. To 
understand why this was, it is first important to understand the factors which dictate the amount o f 
product a PCR reaction will be able to generate. Two theoretical scenarios are described below:
(1) In a theoretical reaction vessel with two templates, which utilise the same primers as well as 
other reagents, and which contains an excess o f all these reagents, the amount o f each product 
generated will again only be limited by the amount if template initially present and the number 
o f cycles the PCR reaction proceeds through. This is a model o f the “competitive” PCR reaction, 
perhaps more accurately termed a parallel PCR reaction, in which the two templates effectively exist 
independently o f each other.
(2) The second scenario, where the independence o f the two templates is destroyed, occurs when a 
reagent (for example, the primer pair) is not in excess. In this case, the amount o f product will be 
limited by the reagent and will not continue to increase at an exponential rate will each successive 
reaction. For example, if there are initially lOOpmoles o f primer pairs and 1 mole o f primer pairs is 
required to generate 1 mole o f PCR product, then the maximum amount o f PCR product that can 
be generated is lOOpmoles, no matter how many cycles the reaction proceeds for. This is the total 
amount o f product for all templates in the reaction vessel. In a two-template reaction the maximum 
amount o f  product from one template becomes dependent on that template’s initial amount relative 
to the initial amount o f the other template. A plasmid which represents 50% of the total amount of 
initial template will only generate 50% of the total amount o f PCR product allowed by the limited
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reagent. To continue the example above, this plasmid will only generate a maximum of 50pmoles 
(50% o f the lOOpmoles allowed) o f PCR product. On its own, this relationship between the two 
different templates does not cause a problem when trying to quantify initial amounts o f template 
DNA. If  the reaction were allowed to run without limit for a longer time, the final relative amounts 
o f each product would be the same.
However, the practical consideration o f measuring the final amounts o f DNA brings to light a 
potential problem. The method o f separating DNA o f different lengths on an agarose gel and 
visualising it by staining with ethidium bromide has practical limitations. As demonstrated in the 
cycle number optimisation experiments (Section 3.2.2.5), the agarose gel system will not allow the 
detection o f DNA below a certain level. Below approximately 25 reaction cycles the amount o f 
DNA produced was not sufficient to show up against the background levels o f fluorescing ethidium 
bromide. Also, above approximately 35 reaction cycles the band intensity reaches a saturation 
point and does not increase in the linear fashion seen with smaller amounts o f DNA (lower cycle 
numbers). These two factors mean the agarose-ethidium detection method for DNA has a limited 
range within which quantification can be made accurately.
In F igure 3.2.6.3 the evidence of a reagent-limited reaction was seen again, this time over a narrower 
range o f DNA concentrations. The band o f undeleted fragment (TNF-aF) should have remained 
at a constant intensity from Lanes B-G. The fall in intensity suggested that the amount o f PCR 
product was not being dictated solely by the initial amount o f the pCR2.1-TNF-a plasmid and 
the cycle number, but also by the amount o f limiting reagent and the relative amounts o f pCR2.1- 
ATNF-a plasmid also present. The mathematical analysis o f the reaction, described in detail in 
Figure 3.2.6.4, showed that the primer concentration used may have been the factor limiting the 
25-cycle reaction.
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In Figure 3.2.6.3, the intensity o f the ATNF-aF band was greater than the TN F-aF band in lane 
C, where the initial amount o f pCR2.1-ATNF-a plasmid was supposed to be 10-fold less than 
that o f pCR2.1-TNF-a. This suggested that the amounts o f DNA added to the reaction were not 
accurate, that the amount o f pCR2.1-ATNF-a plasmid was greater than that o f the pCR2.1-TNF-a 
plasmid, and hence the TN F-aF was decreasing as its tem plate’s relative abundance decreased. A 
spectrophotometric analysis o f the plasmid preparations used in the reaction confirmed that the 
preparation o f pCR2.1-ATNF-a DNA was more concentrated than previously thought (probably 
through experimental error when the preparation was originally made and measured).
With new preparations o f plasmid DNA, measured several times to ensure the estimated concentration 
o f each was accurate, the reaction was performed again, this time successfully. The relative amounts 
o f the ATNF-aF and TN F-aF PCR products seen in Figure 3.2.6.5 accurately mirror the known 
initial amounts o f template DNA. The reaction may have been limited by the primer concentration 
(unchanged from previous reactions) this did not matter when considering the relative amounts of 
each product. This reaction showed that this system could be used to measure an unknown message 
against an internal control o f known concentration if  the factors which affect the amplification and 
measurement o f the PCR products are known and controlled.
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4.1 Introduction
4.1.1 Reporter Assay Systems
When examining the regulation o f expression o f a gene in vivo, measurement o f encoded protein is 
the most physiologically relevant way o f assessing the regulatory factors involved. However it may 
be difficult to assay the protein o f interest as it may be difficult to isolate and quantify. In addition, 
other factors may regulate protein levels, such as the stability o f the encoded protein. M easurement 
o f gene transcription can performed by using a reporter gene.
The basic principle o f a reporter gene system is to couple the regulatory sequences o f the gene 
o f interest to the coding sequence for a more easily assayed gene product, the reporter gene. This 
is typically an enzyme not naturally present in the cell type being studied: common reporter gene 
includes alkaline phosphatase, chloramphenicol acetyl transferase, and luciferase. The experimental 
enzyme can then be harvested and used in a quantifiable in vitro reaction.
4.1.2 Luciferase Reporter Assay
The term Luciferase refers to a number o f unrelated proteins, which catalyse similar chemical reac­
tions. These reactions typically produce light as their primary product and form the enzymatic basis 
o f the phenomenon of bioluminescence, found in several species o f insect and plant. These enzymes 
form the basis for a reporter gene system where light is generated and the amount detected is related 
to the level o f expression o f the luciferase gene. Using this principle and considered experimental 
design, the action of the promoter sequence can be determined.
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The two major luciferase enzymes used in reporter systems o f this type are found naturally in the 
Firefly, Photinus pyralis, and the sea pansy, Renilla reniformis. While their uncommon and specific 
function suggests a common ancestry and mechanism, the luciferase enzymes in these two species 
are distinct from each other in evolutionary terms and differ in their substrate.
4.1.2.1 Photinus pyralis Firefly Luciferase
This enzyme is a 61kDa monomeric protein that is active immediately upon primary translation 
and does not require any post-translational modifications such the cleavage o f a signal sequence or 
glycosylation. The light-generating reaction catalysed is a single step oxidation step. The substrate 
Beetle Luciferin is converted to Oxyluciferin. ATP and molecular oxygen are required as cosub­
strates and ionic Magnesium (Mg2+) is required as an enzymic cofactor. (See Figure 4.1.2.1 A)
4.1.2.2 Renilla reniformis Sea Pansy Luciferase
This is a 36kDa protein that is 3% glycosylated in its natural form, although like Firefly Luciferase 
it is fully active immediately upon translation. The reaction catalysed is similar but distinct from the 
Firefly reaction described above. Again, it is a one-step oxidation reaction utilizing the substrate 
Coelenterazine and molecular oxygen. (See Figure 4.1.2.2 B)
4.1.3 Luciferase Reporter Plasmids
The luciferase gene used in the reporter gene system is encoded on a plasmid containing the cDNA 
for the natural luciferase mRNA. Several different types o f luciferase plasmid were used in the work 
reported here and they are described in detail below.
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4.1.3.1 pGL3-Basic
This plasmid (shown in Figure 4.1.3.1), of just under 5000bp in length, contains the coding sequence 
o f the cytosolic form o f Firefly luciferase (luc+) with a multiple cloning site upstream o f the start 
codon to allow insertion o f regulatory DNA sequences. A synthetic poly(A) sequence upstream o f 
this prevents opportunistic translation o f the gene by the random binding o f transcription factors 
upstream o f the coding region. It also contains the ampicillin resistance gene (Amp1)  to allow for 
selection when the plasmid is transformed into bacterial strains.
This plasmid allows background levels o f expression o f the luc+ gene to be evaluated. It also pro­
vides the vector into which the promoter sequence o f interest can be inserted.
4.1.3.2 pGL3-Control
This plasmid (shown in Figure 4.1.3.2) is similar to pGL3-Basic but with the addition o f an SV40 
promoter between the multiple cloning site and the luciferase gene and an SV40 enhancer sequence 
immediately downstream o f the SV40 late poly(A) signal found at the end o f the coding sequence. 
The SV40 promoter and enhancer are derived from the SV40 virus and genes coupled to them are 
constitutively activated, to varying degrees, in a wide range o f eukaryotic cells. Therefore the pGL3- 
Control plasmid provides a positive control plasmid for expression o f Firefly luciferase in vivo.
4.1.3.3 pRL-SV40
This plasmid (shown in Figure 4.1.3.3) contains the SV40 Early Enhancer/Promoter sequence 
driving expression o f R luc, an engineered form of the luciferase found in Renilla reniformis. This
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provides constitutive expression of the Renilla luciferase. The plasmid also contains the ampicillin 
resistance gene, Ampr, to allow for selection when growing the plasmid in bacterial culture.
4.1.4 Single and Dual Luciferase Assays
While transfecting a cell culture with one luciferase reporter plasmid can show that the cells 
will express active luciferase enzyme, it cannot be used to measure promoter activation without 
an internal control for transfection efficiency. Without this control it would be unclear whether ' 
any variation in luciferase activity seen between experimental conditions was due a differential 
activation o f the gene by the promoter or different levels o f plasmid DNA in the cells. An internal 
control provides a baseline o f activity, which can be directly related to transfection efficiency, 
and thus experimental data on promoter activation can be normalised against this baseline giving 
a more accurate result. To provide this internal control in the luciferase system, two luciferase 
reporter plasmids are co-transfected into the cell. The first is the experimental plasmid containing 
the promoter sequence o f interest coupled to the Firefly luciferase gene. The second plasmid 
consists o f a viral promoter sequence coupled to the Renilla luciferase gene, which will give 
constitutive expression o f the Renilla luciferase. As the Firefly and Renilla luciferases use different 
substrates, their activities can be measured independently o f each other without having to separate 
them from each other when the cells are harvested and cell lysates are prepared.
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Firefly
Luciferase
HO,
♦ AMP ♦ PP, +CO, + Light+ ATP + O,
OxyluciferinBeetle Luciferin
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+ CO, + Light
HO'HO'
Coelenterazine Coelenteramide
Figure 4.1.2.1 Reactions catalysed by Firefly and Renilla Luciferases
The light-generating reactions catalysed by the Firefly and Renilla luciferases 
are both one-step processes and utilise different substrate molecules, an 
indication o f the distinct and separate evolutionary origins o f the two enzymes.
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Figure 4.1.3.1 Schem atic of pGL3-Basic Luciferase Expression Plasm id
The pGL3-Basic plasmid features the Firefly luciferase enzmye coding sequence with a 
multiple cloning site immediately upstream.
Chapter 4: Reporter Gene Assay
Amp
f1 ori
Kpn I 
Sac I 
Mlu I 
Nhe I 
Sma I 
Xho I
eg / ii
ori
pGL3-Control
Vector
(5257bp)
Synthetic poly(A) 
signal
SV40 Promoter
Sal I 
BamH I
SV40 Enhancer
SV40 late poly(A) 
v signal
luc+
Figure 4.1.3.2 Schem atic of pG L3-C ontrol Luciferase Expression Plasm id
The pGL3-Control plasmid features the Firefly luciferase coding sequence coupled to the SV40 
upstream promoter and downstream enhancer elements. This ensures constitutive expression 
across a wide range of eukaryotic cell types.
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Figure 4.1.3.3 Schematic of pRL-SV40 Luciferase Expression Plasmid
The pRL-SV40 plasmid couple the Renilla luciferase coding sequence to a combined SV40 
upstream promoter/enhancer. This provides constitutive expression across a wide range of 
eukaryotic cell types.
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4.2 Results
4.2.1 Preparation of Plasmid DNA
Preparations o f PGL3-Control, pGL3-Basic and pRL-SV40 plasmid DNA were made by transforming 
bacteria with plasmid DNA and growing colonies on agar plates, selecting for ampicillin resistance. 
Suitable colonies were picked and used to grow cultures in LB medium. Plasmid DNA was purified 
from these cultures by maxiprep. The concentration o f DNA was measured spectrophotometrically.
4.2.2 Single Luciferase Transfections
A successful Luciferase assay system is one in which sensitivity and accuracy is balanced against an 
efficient use o f resources. It was therefore necessary to investigate the effect o f several experimental 
variables on measurable Luciferase activity to arrive an optimal set o f conditions for further work. 
The variables tested were the amount o f DNA transfected, the time of incubation after transfection, 
and the concentration o f Enhancer, a reagent used in the transfection process.
4.2.2.1 Amount of DNA Transfected
l(ig, 2|ig, 5pg and 10|ig o f either pGL3-Control or pGL3-Basic plasmid DNA were transfected into 
3 x 106 cells in a final volume of 5ml o f RPMI medium. These cultures were then incubated for 24 
hours and the cells were harvested using lysis protocol 1 and cell lysates were assayed immediately 
for Luciferase activity using the single luciferase assay system. The results are plotted in Figure 
4.2.2.1,
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Luciferase activity initially increased with the amount o f pGL3-Control DNA transfected and 
reached a maximum with 5|LXg. The activity then decreased approximately 100-fold when lOjig o f 
DNA was transfected.
Luciferase activity when cells were transfected with pGL3-Basic did not vary significantly with the 
amount o f DNA between 1 and 5|ig, although there was a dramatic decrease in activity when lOpg 
was used. Activity was negligible when compared to the pGL3-Control-transfected cells, being 
between and 500 and 4000-fold less for corresponding amounts o f DNA.
While 5(ig o f DNA gave the highest activity it was decided to use 2|ig o f DNA in subsequent 
transfections. This would give an activity which was typically only 10% less than when using 5(ig 
but which would consume only 40% of the DNA. This would allow more transfections to be carried 
out using the same preparations of DNA.
4.2.2.2 Period of Incubation
2pg o f either pGL3-Control or pGL3-Basic DNA was transfected into 3 x 106 cells in a final volume 
of 5ml o f RPMI medium and the cells were then incubated for 24, 48 or 72 hours before being 
harvested using lysis protocol 1 and immediately assayed using the single luciferase assay system. 
The results are plotted in Figure 4.2.2.2.
Luciferase activity was highest at the 24-hour time point and decreased rapidly after this, although 
activity was still large enough to be measured with a high degree o f accuracy. This was true for both 
the pGL3-Control-transfected cells and the pGL3-Basic-transfected cells, although the difference in 
magnitude between the two plasmids was 1000-1500 fold throughout the time course.
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4.2.2.3 Concentration of Enhancer Reagent
2|ig o f pGL3-Control DNA was transfected into 3 x 106 cells in a final volume o f 5ml RPMI medium 
with either 4(xl, 6pl, 8 jll1, 10pl or 1 2 | ll1 of Enhancer reagent. The volume o f buffer was altered in 
each case to give each DNA/Enhancer/Effectene mixture a consistent volume. The cell cultures were 
incubated for 24 hours and harvested using lysis protocol 2, before being assayed immediately using 
the single luciferase assay system. The results are plotted in F igure 4.2.2.3. There was no significant 
variation in the measured luciferase activity for the five experimental conditions.
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□  pGL3-Control
Amount of DNA Transfected
Figure 4.2.2.1 Firefly Luciferase Activity vs. A m ount of Plasm id DNA 
Transfected
Cells were transfected with l-10)Ltg of either pGL3-Control or pGL3-Basic 
plasmid DNA, incubated for 24 hours and harvested. Firefly luciferase activity 
was then assayed. The graph shows the mean of three separate transfections, 
each measured in triplicate, and the standard deviation of the mean.
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pGL3-Control
24 Hours 48 Hours 72 Hours
Time of Incubation
Figure 4.2.2.2 Firefly Luciferase Activity vs. Tim e of Incubation
Cells were transfected with 2pg o f pGL3-Control or pGL3-Basic plasmid DNA and 
incubated for 24, 48 and 72 hours. They were then harvested and Firefly luciferase 
activity was assayed. The graph shows the mean of three separate transfections, each 
measured in triplicate, and the standard deviation o f the means.
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Figure 4.2.2.3 Firefly Luciferase Activity vs. A m ount of E nhancer
Cells were transfected with 2pg o:' pGL3-Control plasmid DNA. The amount of 
Enhancer regeant used in the transfectionwas varied from 4 to 12jnl. The cells were 
incubated for 24 hours, harvested and Firefly luciferase activity was measured. The 
graph shows the means of three separate transfection series, each o f which was 
measured in triplicate, and the standard deviation o f the means.
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4.2.3 Dual Luciferase Transfections
4.2.3.1 Initial Transfection
2|iig o f pRL-SV40 DNA was cotransfected with 2pg of either pGL3-Control or pGL3-Basic DNA 
into 3 xlO6 cells in a final volume of 5ml of RPMI medium. The cultures were incubated for 24 hours 
and the cells harvested using lysis protocol 2. Firefly and Renilla Luciferase activity in the lysates 
was then measured, using the Dual Luciferase Assay protocol. The results are plotted in Figure 
4.2.3.1.
The results showed a large difference in measured activity between the two types o f Luciferase 
and also a difference in Renilla luciferase activity depending on which Firefly luciferase plasmid 
it was co-transfected with. In the co-transfection o f pRL-SV40 and pGL3-Control, where the two 
luciferase genes were under the control o f similar SV40 promoter elements, the Renilla luciferase’s 
activity was typically more than twice that o f the Firefly luciferase. When co-transfected with pGL3- 
Basic, the activity o f the Renilla Luciferase was much reduced, falling to below that o f Firefly 
luciferase as expressed by the pGL3-Control plasmid.
4.2.3.2 Variation in Amount of pRL-SV40 DNA Transfected
2pg of pGL3-Control DNA was co-transfected with either 2pg, lpg , 0.5|lg, 0.25|ig or O .lpg of 
pRL-SV40 DNA in cell cultures of 3 x 106 cells in a final volume of 5ml RPMI medium. The cultures 
were incubated for 24 hours, harvested and assayed using the Dual Luciferase Assay protocol. The 
results are plotted in Figure 4.2.3.2.
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The results showed a steady decrease in Renilla luciferase activity followed a decrease in the amount 
of pRL-SV40 DNA transfected. Initially, with the amounts of pRL-SV40 and pGL3-Control DNA 
the same (2|ig each) the activity of Renilla luciferase was approximately 8 fold that of the Firefly 
luciferase. As the activity of Renilla luciferase fell there was a steady increase in Firefly luciferase 
activity, and when the amount of pGL3-Control DNA transfected was 8 fold that of pRL-SV40, 
the activities of the two luciferases were comparable. When the Firefly luciferase activity was used 
as a control for transfection efficiency and the two activities were expressed as a ratio, the Renilla 
luciferase activity being normalied by the Firefly luciferase, the result was a linear relationship 
between the amount of pRL-SV40 DNA transfected into the cells and the activity of the Renilla 
luciferase expressed by the cells.
4.2.4 Generation of Promoter-Luciferase Plasmid Constructs
The strategy for making pGL3 luciferase expression plasmids containing the T N F-a and IL-6 gene 
promoters consisted of two main stages. In the first stage the promoters would be amplified from cell 
DNA by PCR and in the second stage the promoter fragments would be subcloned into the pGL3- 
Basic plasmid at the multiple cloning site.
4.2.4.1 Sequence Analysis and PCR Primer Design
The promoter sequence of each gene was retrieved from the Genbank database and primers were 
designed to amplify a region at least lkb  in length immediately upstream of the transcription 
initiation start codon. The primers were designed following the criteria set out in section 3.2.2.2. 
Two sets of primers were designed to make available four possible combinations of forward and 
reverse primers. The primer sequences are shown in Table 4.2.4 below.
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Table 4.2.4 Primers for PCR of Gene Promoters
Primer
TNF-a Forward 1
TNF-a Reverse 1
TNF-a Reverse 2
IL-6 Forward 1
IL-6 Reverse 1
IL-6 Forward 2
IL-6 Reverse 2
Sequence (5’-3’)
GAT GTG ACC ACA GCA ATG GGT AGG
CAT GCT TTC AGT GCT CAT GGT GTC C
TNF-a Forward 2 G AA TG T C C A G G G  C TA  TG G  AAG  TC G  AG
CAG TGC TCA TGG TGT CCT TTC CAG
GAG ACA CCA TCC TGA GGG GAA GAG GG
CTT GTG GAG AAG GGA GTT CAT AGC
GGA ATC CTC CTG CAA GAG ACA CCA TC
CTA AGG ATT TCC TGC ACT TAG TTG TG
4.2.4.2 PCR Amplification of Prom oter Sequences
PCR amplification was performed on genomic DNA prepared from untreated U937 cells. Initially, 
each primer pair was used separately giving two primer combinations for each promoter. This 
produced the result seen in Figure 4.2.4.1. The primer pairs for the IL-6 promoter sequence did not 
produce a fragment of the correct size but both primer pairs for the T N F-a promoter did produce a 
fragment of the correct size. Further PCR reactions using all four combinations of the IL-6 primers, 
over a range of conditions failed to generate the IL-6 promoter fragment.
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4.2.4.3 Construction of pGL3-TNFP Plasmid
Instead of trying to subclone the T N F-a promoter fragment directly into the pGL3-Basic plasmid, it 
was decided first to subclone the fragment into the pcDNA3.1/V5-His-TOPO vector. The fragment 
could then be excised using two restriction enzymes and inserted into the multiple cloning site of 
the pGL3-Basic plasmid in the correct orientation.
The first subcloning step used the TA cloning method, where the fragment has a single deoxy adenosine 
(A) overhang at the 3’ end of each strand and the vector has a single deoxy thymidine (T) overhang at 
the end of each strand, which will anneal together. However, the PCR fragment had been generated 
with the polymerase Pfu, which does not leave an overhang on the fragment. Therefore the fragment 
was given an overhang by incubation with Taq polymerase at 72°C for 30 minutes. The Taq was 
added directly to the PCR reaction so no further dATP needed to be added. The PCR fragment was 
then gel purified and subcloned into the pcDNA3.1/V5-His-TOPO vector. This plasmid was used to 
transfect bacterial cells, from which miniprep cultures were prepared. The plasmid DNA prepared 
from these cultures was purified and digested to excise the promoter insert. The results of the digest 
are shown in Figure 4.2.4.2. Lane F showed a positive result with an insert of the correct size.
This plasmid and the pGL3-Basic plasmid were then both digested with the restriction enzymes 
A sp l 18 (a Neoschizomer of Kpn I) and Xho I, and the products were run on a gel (Figure 4.2.4.3) 
and purified from this. The excised T N F-a promoter fragment and the linearised pGL3-Basic were 
ligated together and the resulting plasmid was amplified by bacterial transformation and miniprep 
culture. The plasmid DNA isolated from these minipreps was then digested with A sp !\$  and Xho 
I to excise the insert. The digests are shown in Figure 4.2.4.4. All ten plasmid clones contained 
the TN F-a promoter insert. The plasmid in clone 1 was used generate larger amounts of DNA by
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maxiprep, which was stored for use in transfections.
4.2.5 Dual Luciferase Transfection with pGL3-TNFP Plasmid
4.2.5.1 Treatment with IFN-y and dbcAMP
To establish a baseline of expression for the pGL3-TNFP plasmid, cells were transfected with both 
it and pRL-SV40 and then treated with IFN-y and/or dbcAMP for periods of 18 and 36 hours.
A culture of cells large enough to provide 3 million cell aliquots for each of the conditions was 
grown and transfected with 2pg of pGL3-TNFP and 2jig of pRL-SV40 DNA per 3 million cells. 
After 6 hours the cells were split into individual aliquots and treated. They were incubated, harvested 
and assayed as before. The results are plotted in Figure 4.2.5.1,
After 18 hours there is small increase in activity over the control (no treatment) when the cells 
were treated with IFN-y. This is true for both the individual treatment and the dual treatment with 
dbcAMP. Treatment with dbcAMP alone did not significantly alter the expression from the control.
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Figure 4.2.3.1 Dual Luciferase Assay
Cells were transfected with 2|ig of pGL3-Control or pGL3-Basic and 2pg o f pRL-SV40 
plasmid DNA and incubated for 24 hours before harvesting and assay o f Firefly and 
Renilla luciferase activities. The graph shows the means o f three separate transfections, 
each of which measured in triplicate, and the standard deviation of these means.
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Figure 4.2.3.2 Renilla  Luciferase activity vs. A m ount of pRL-SV40 transfected
Cells were transfected with 2pg o f pGL3-Control and varying amount o f pRL-SV40 
plasmid DNA, incubated for 24 hours and harvested before Firefly and Renilla 
luciferase activities were assasyed. The graph shows the means o f three separate 
transfection, each of which was measured in triplicate, and the standard deviations of 
those means.
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Figure 4.2.4.1 PCR of IL -6/TN F-a Prom oter Sequences
A PCR reaction was performed using a template of genomic 
DNA isolated from untreated U937 cells. Primer pairs for 
the promoter sequences o f IL-6 (Lanes B and C) and TN F-a 
(Lanes D and F) were used against this. Lane F shows the 
IL-6F positive control.
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1OOObp 
500bp
Figure 4.2.4.2 M iniprep Digest of pcDNA3.1-TNFP Plasm id C onstruct
Gel-purified TNFP PCR product was subcloned into pcDNA3. l/V5-His-TOPO vector and 
miniprep cultures were generated from this construct. Lanes B-K show 10 o f these plasmid 
DNA preps digested with EcoKI.
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Figure 4.2.4.3 Digest of pGL3-Basic and pcDNA3.1-TNFP Plasm ids
The plasmids pGL3-Basic and pcDNA3.1-TNFP were digested with the restriction 
enzymes Asp? 18 and Xho I.
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500bp
Figure 4.2.4.4 Digest of pG L3-TN FP Plasm id DNA
The TNFP fragment was ligated into the multiple cloning site o f the pGL3-Basic luciferase 
expression plasmid. This construct was used to transform bacteria and miniprep cultures 
were grown from these cells before the plasmid was purified from them and digested with 
Asp7l8  and Xho I to excise the promoter fragment. Lanes B-K show ten o f these digests.
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36 HourTreatment
IFN-y/dbcAMPControl dbcAMP
Treatment
Figure 4.2.5.1 pG L3-TN FP Response to IFN-y/dbcAM P T reatm ent
Cells were transfected with 2fig of pGL3-TNFP and 2pg o f pRL-SV40 plasmid DNA then 
treated with IFN-y and/or dbcAMP before incubation for 18 and 36 hours. The cells were 
then harvested and Firefly and Renilla luciferase activities were assayed. The graph shows 
the mean values of three separate transfections, each measured in triplicate, and the 
standard deviations of the means.
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4.3 Discussion
This chapter describes work carried out to create a reporter gene assay for the study o f the 
gene regulation o f cytokine promoters. The work was successful in generating a reporter plasmid 
construct consisting o f the T N F-a promoter coupled to the firefly luciferase cDNA.
4.3.1 Single Luciferase Assays
The U937 cell line had been used extensively in the lab prior to this work, but had never been 
successfully transfected with DNA. The initial transfections, which were carried out using the 
pGL3-Control plasmid was the positive control and the pGL3-Basic plasmid was the baseline 
for no promotion o f gene expression (although the gene itself was present), showed that the 
transfection reagent used was successful in transfecting the cells. The technique involved a one- 
step addition o f the DNA-reagent mix and observation o f the culture o f cells after this did not 
reveal a large toxic effect in terms o f the number o f viable cells left after the incubation period.
The expression o f the luciferase protein was easily detected with the activity o f  the positive control 
generally being 3 to 4 orders o f magnitude greater than that of the negative.
While it was encouraging to find the reporter system working well from the outset, it was 
important to more closely characterise the expression o f the enzyme to provide the data needed to 
plan effective experiments in the future. It was unlikely that the cytokine promoters would generate 
the same kind o f expression as the SV40 promoter/enhancer combination o f the pGL3-Control 
plasmid, so it may have been necessary to increase (or decrease) the amount o f DNA transfected to 
produce enough active enzyme to be measured accurately and easily. The measurement o f activity 
over a range o f amounts o f DNA (Figure 4.2.2.1) showed that the amount o f DNA chosen (2pg)
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was adequate to give a high activity, that half this amount still gave acceptable values and that there 
was a limit as DNA transfected increased beyond which the activity declined sharply. This decline 
in activity was not accompanied by a decline in cell vigour as observed through the microscope, so 
the reason may have been a more subtle toxic effect o f the DNA or transfection reagent.
The incubation time was also a crucial factor when considering future experiments which would 
involve treatment with IFN-y and dbcAMP followed by incubation periods to allow activation or 
differentiation to occur and cross-linking o f Fc receptors, which would again require an incubation 
period to allow cellular activation to transpire. The activity dropped off steadily from 24 hours 
of incubation so it would be useful for subsequent work to allow this time period o f incubation 
between transfection and harvest. However, the activity after 72 hours, although just over 6-fold 
less than after 24 hours, was still orders o f magnitude higher than the baseline and so it would be 
possible for incubation periods o f this length to generate useful data.
4.3.2 Dual Luciferase Assays
To control for transfection efficiency when measuring and comparing the levels o f firefly luciferase 
activity in separate transfections, an internal control, the Renilla luciferase pRL-SV40 plasmid, 
was used. This was co-transfected with the firefly luciferase plasmid and measured using the Stop 
and Glo dual luciferase system.
Initial experiments showed the Firefly and Renilla plasmids could be co-transfected and expressed 
successfully in the U937 cell line. The fact that there was also a linear relationship between 
the amount o f Renilla plasmid DNA transfected and the light intensity measured (see Section 
4.2.3.2) suggested the pRL-SV40 plasmid as a good choice for an internal control versus the
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pGL3-Promoter plasmid.
4.3.3 Construction of the Promoter-Luciferase Plasmid Constructs
The promoter o f a gene is only present at the level o f nuclear genomic DNA, with only one copy 
available for amplification in each cell. However, unlike the amplification o f cDNA derived from 
cell mRNA the activation state o f the cell in this case should have little bearing on the subsequent 
PCR amplification if the genomic DNA is correctly purified from a culture o f cells. Therefore, the 
major variable in the success o f such an amplification is the primer pair used. To provide a greater 
chance o f amplifying the desired length o f promoter sequence, two sets o f forward and reverse 
primers were designed for each of the promoters. This provided four combinations o f forward 
and reverse primers to use in each promoter sequence amplification. The result o f  numerous 
reactions, with variations in all the parameters, was a promoter sequence for T N F-a successfully 
amplified but no sequence from the IL-6 promoter. Given that genomic DNA in vivo is closely 
associated with histone proteins in a complex, 3-dimensional arrangement, it is possible that 
new secondary and tertiary structures could be created when the DNA is separated from the 
protein during purification. This new conformation may even persist to some extent when the 
genomic DNA is denatured during the PCR cycle. This could explain the lack o f any significant 
amplification product in any o f the IL-6 promoter PCR reactions.
The design o f the primer sets for the PCR reactions also had a bearing on the subsequent subclon­
ing protocol used to create the complete Luciferase-Promoter construct. Two approaches were 
considered. The first, which was eventually utilised, involved the two-step, two-vector protocol 
described in Section 4.3.4. The second approach involved the modification o f sequence at the 
termini o f the promoter fragment. The insertion o f the promoter sequence into the multiple
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cloning o f the pGL3-Basic plasmid required that the ends o f the promoter featured complementary 
overhangs, in the correct orientation, to the restriction sites available on the plasmid. Analysis 
o f  the promoter sequence revealed, as expected, that the termini o f the hypothetical fragment 
did not contain these restriction sites. Therefore, primers were designed which, although mostly 
complementary to the genomic DNA, contained nucleotide changes that would introduce the 
required restriction sites into a subsequently amplified PCR fragment.
However, several preliminary PCR reactions showed no evidence that the primers could be mutated 
in this way and still retain the desired level o f affinity for the specific sequences in the promoters. 
Therefore the two-step process was chosen even though this would introduce additional sequence 
from the pcDNA3.1 vector at either end o f the promoter. It was considered that this would not 
inhibit the function o f the promoter in regulating expression o f the luciferase gene to an extent that 
would limit the plasm id’s experimental uses, given that the multiple cloning site o f the pGL3-Basic 
plasmid would itself introduce intervening nucleotides.
4.3.4 Experiments with the pGL3-TNFP Plasmid
The pGL3-TNFP plasmid was used in only one preliminary experiment during the work covered 
by this thesis. The U937 monocyte/macrophage differentiation system requires treatment o f the 
cells with either IFN-y or dbcAMP to give the desired phenotypes. Therefore, before the effects 
o f cross-linking and activating FcyRI on the expression o f luciferase through the T N F-a promoter 
could be measured, the baseline changes in expression due to the treatments had to be assessed.
The result o f  this experiment (Figure 4.2.5.1) suggested that the T N F-a promoter was down- 
regulating the expression o f luciferase as the U937 cell was differentiated to a more macrophage­
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like phenotype, while IFN-y had no effect on the promoter individually and did not alter the effect 
o f the dbcAMP when used to co-treat the cells with it. W hat this suggested for future experiments 
where FcyRI was activated was that in the IFN-y-treated cells the process o f activation itself would 
not contribute significantly to any up- or down-regulation in expression o f the luciferase gene and 
therefore any results would not be complicated by the effect o f this variable. The same would not 
be true in the dbcAMP-differentiated cells but if parallel controls were performed to measure the 
contribution o f differentiation on expression this variable would not obscure any effects the FcyRI 
was having on the expression o f the gene.
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5.1 Conclusion
This thesis describes the work undertaken in the design and development o f two assay systems 
intended for use in measuring gene expression downstream o f activation o f the high affinity Fc 
receptor for IgG, a key component o f the immune system. The main objectives that were achieved 
are summarised below:
• Lengths o f sequence from the 3’-untranslated regions o f the human T N F-a and IL-6 
mRNAs were amplified by RT-PCR to generate DNA fragments, which were subcloned 
into plasmid vectors
• An internal PCR methodology was used to delete regions from these fragments and 
subsequent subcloning o f the fragments created plasmid constructs for use in quantifying 
mRNA by competitive PCR
• The accurate quantification o f DNA was demonstrated in primciple using the pair o f TN F-a 
fragment plasmids
• U937 cells were transfected with two types o f luciferase reporter gene and expression o f
these genes was demonstrated through measurement o f light given off by their enzymic 
action
• The promoter sequence o f the TN F-a gene was amplified by PCR and inserted as the 
regulatory sequence in a luciferase expression vector
• The promoter-reporter construct was used to investigate the effect induced differentiation o f 
the U937 cell line had on T N F-a expression
In essence, this work is the first stage in investigating the relationship between FcyRI and the 
T N F-a and IL-6 genes. The process o f developing an assay by applying a number o f basic
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molecular tools (the enzymes used to perform RT-PCR, the luciferase expression vectors) and 
information (nucleic acid sequences for the genes and mRNAs o f TN F-a and IL-6) to an in 
vitro cell model such as the U937 monocyte/macrophage system was one which demonstrated the 
unexpected complexities one has to contend with when approaching biological research. However, 
the nature o f the problems encountered meant that those complexities were investigated and 
understood to a high degree, an important benefit when proceeding forward using these tools.
In terms o f future work, I see these two assays as ways in which to investigate the final stage in 
translation o f information from extracellular signal to the ultimate cellular response: the expression 
of signal molecules which would provide the next step in the wider co-ordinated immune response. 
Previous work cited in this thesis (Melendez et al, Davis et al, Harrison et al) has described in 
detail the complex and novel way in which FcyRI operates at the centre o f the immune system, 
linking the humoral and cellular arms together. Utilisation o f these assays would allow the nuclear 
events triggered by the FcyRI-activated signalling cascades to be elucidated and thus provide an 
unbroken description o f the signal through the macrophage and monocyte cell types.
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